203 results on '"R. Garrel"'
Search Results
2. Tratamiento quirúrgico del divertículo faringoesofágico
- Author
-
M. Dallemagne, V. Favier, and R. Garrel
- Subjects
Microbiology (medical) ,Immunology ,Immunology and Allergy ,General Medicine - Published
- 2022
- Full Text
- View/download PDF
3. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases
- Author
-
A. Varoquaux, L. Castillo, M. Tassart, R. Jankowski, Emmanuelle Uro-Coste, F. Massip, L. Brugel, S Testelin, René-Jean Bensadoun, Olivier Mauvais, C. Bach, P. Herman, Christian-Adrien Righini, Laurent Gilain, Xavier Dufour, T. Mom, L. Laccoureye, E. Baudin, Justin Michel, Ludovic Le Taillandier de Gabory, G. Moulin, D. de Raucourt, C. Ferron, Juliette Thariat, R. Breheret, J.-M. Badet, V. Darrouzet, Bruno Devauchelle, T. Radulesco, Bertrand Baujat, V. Strunski, G. Poissonnet, Thomas Radulesco, Jean-Claude Merol, Renaud Garrel, C. Borel, A. Cosmidis, Odile Casiraghi, Dominique Chevalier, E. Serrano, Caroline Even, J.-C. Merol, P. Demez, L. Geoffrois, N. Fakhry, J.-P. Lavieille, A. Banal, J. Lacau St Guily, S. Duflo, J.-P. Bessède, B. Baujat, Marie Christine Kaminsky, F. Chabolle, Sebastien Albert, Roch Giorgi, O. Sterkers, N. Sarroul, Vianney Bastit, D. Blanchard, P. Lang, E. de Monès, P. Breton, G. Dolivet, R. Garrel, Sébastien Vergez, B. Toussaint, Anne Sudaka, A. Giovanni, G. Noel, P. Hofman, A. Bozorg-Grayeli, O. Malard, M. Housset, E. Lartigau, P. Ceruse, Valérie Costes-Martineau, C. Bertolus, Cécile Badoual, G. Andry, T. Van den Abbeele, F. Kolb, S. Faivre, F. Floret, P. Dessi, M. Juliéron, Nicolas Fakhry, J. Michel, Louis Crampette, Francois Mouawad, O. Choussy, Philippe Schultz, S. Hans, Marine Lefevre, L. Gilain, Emile Reyt, Sylvain Morinière, Philippe Herman, G. Valette, Béatrix Barry, A. Timochenko, Gilles Poissonnet, Antoine Moya-Plana, F. Veillon, S. Vergez, A. Coste, Franck Jegoux, E. Cassagnau, Christine Bach, Y. Marie Robin, B. Guerrier, E. Uro Coste, X. Leroy, Valérie Costes, Olivier Malard, F. Rolland, F. Dubrulle, A.C. Baglin, L. de Gabory, B. Ruhin, A. Girod, G. Calais, Laurie Saloner Dahan, Emmanuel Babin, J.C. Chobaut, Michel Wassef, Benjamin Lallemant, Jean-Michel Prades, C.-A. Righini, Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Aix Marseille Université (AMU), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital de la Timone [CHU - APHM] (TIMONE), Biostatistique et technologies de l'information et de la communication (BioSTIC) - [Hôpital de la Timone - APHM] (BiosTIC ), Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), CHU Toulouse [Toulouse], CHU Bordeaux [Bordeaux], CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Institut Universitaire de la Face et du Cou [Nice], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre hospitalier universitaire de Nantes (CHU Nantes), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Hôpital Foch [Suresnes], CHU Lille, Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), CHU Clermont-Ferrand, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Centre Hospitalier Universitaire [Grenoble] (CHU), Institut Gustave Roussy (IGR), Département de cancérologie cervico-faciale [Gustave Roussy] (CCF), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU), REFCOR members: S Albert, G Andry, E Babin, C Bach, J-M Badet, C Badoual, A C Baglin, A Banal, B Barry, E Baudin, B Baujat, R J Bensadoun, C Bertolus, J-P Bessède, D Blanchard, C Borel, A Bozorg-Grayeli, R Breheret, P Breton, L Brugel, G Calais, O Casiraghi, E Cassagnau, L Castillo, P Ceruse, F Chabolle, D Chevalier, J C Chobaut, O Choussy, A Cosmidis, A Coste, V Costes, L Crampette, V Darrouzet, P Demez, P Dessi, B Devauchelle, G Dolivet, F Dubrulle, S Duflo, X Dufour, S Faivre, N Fakhry, C Ferron, F Floret, L de Gabory, R Garrel, L Geoffrois, L Gilain, A Giovanni, A Girod, B Guerrier, S Hans, P Herman, P Hofman, M Housset, R Jankowski, F Jegoux, M Juliéron, M-C Kaminsky, F Kolb, J Lacau St Guily, L Laccoureye, B Lallemant, P Lang, E Lartigau, J-P Lavieille, M Lefevre, X Leroy, O Malard, F Massip, O Mauvais, J-C Merol, J Michel, T Mom, S Morinière, E de Monès, G Moulin, G Noel, G Poissonnet, J-M Prades, T Radulesco, D de Raucourt, E Reyt, C Righini, Y Marie Robin, F Rolland, B Ruhin, N Sarroul, P Schultz, E Serrano, O Sterkers, V Strunski, A Sudaka, M Tassart, S Testelin, J Thariat, A Timochenko, B Toussaint, E Uro Coste, G Valette, T Van den Abbeele, A Varoquaux, F Veillon, S Vergez, M Wassef, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Laboratoire Parole et Langage (LPL), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), dormoy, valerian, Pathogénèse et contrôle des infections chroniques (PCCI), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier )
- Subjects
medicine.medical_specialty ,Multivariate analysis ,[SDV]Life Sciences [q-bio] ,Salivary glands ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Mucoepidermoid carcinoma ,Internal medicine ,Diabetes mellitus ,Medicine ,Stage (cooking) ,Intermediate Grade ,030223 otorhinolaryngology ,Prospective cohort study ,ComputingMilieux_MISCELLANEOUS ,Cancer ,[PHYS]Physics [physics] ,business.industry ,General Medicine ,medicine.disease ,3. Good health ,Parotid gland ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Surgery ,business - Abstract
International audience; Background: To describe the characteristics of the largest European study of MEC of salivary glands and to determine the prognostic factors for overall and disease free survival.Patients and methods: Patients with MEC were prospectively included in the Réseau d'Expertise Français sur les Cancers ORL Rares (REFCOR, French Network of Rare Head and Neck Tumors) database between 2009 and 2015.Results: A total of 292 patients were included. Tumors were classified as low grade in 175 cases (60%), intermediate in 39 (13%) and high grade in 78 (27%). Median follow-up was 26 months. The 5-year OS and DFS rates were respectively 83% and 69%. In multivariate analysis, age (p = 0.004), diabetes (p = 0.02) and advanced stage (p = 0.03) were found to have a significant negative impact on OS. Diabetes (p = 0.001), alcohol consumption (p = 0.003) and advanced stage (p = 0.001) were found to have a significant negative impact on DFS. Compare to low grade, high grade tended to have a negative impact on OS (p = 0.05) and had a significant effect on DFS (0.002) while intermediate grade had no significant influence on survival. The surgical treatment had a positive impact on both OS (p = 0.00005) and DFS (p = 0.0005). Postoperative radiotherapy had no impact in multivariate analysis.Conclusion: Advanced clinical stage, high grade tumor, high age, the impossibility of carrying out a complete surgical resection, and diabetes are the main prognostic factors in this prospective series of patients with MEC. Such findings open new research perspectives on the influence of these components on initial patient care.
- Published
- 2020
- Full Text
- View/download PDF
4. Utilisation de la valeur de p et des termes « significatif », « non significatif », « suggestif » dans les résumés des articles scientifiques des Annales Européennes d’Otorhinolaryngologie et de Pathologie Cervico-faciale
- Author
-
P. Bonfils, C. Vincent, C. Martin, R. Jankowski, C. Righini, O. Laccourreye, R. Garrel, M. Makeieff, N. Leboulanger, A. Karkas, and Q. Lisan
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Otorhinolaryngology ,Surgery ,030212 general & internal medicine ,030223 otorhinolaryngology - Abstract
Resume Objectifs Evaluer l’utilisation de la valeur de p et des termes « significatif », « non significatif » et « suggestif » dans le resume des articles scientifiques des Annales Europeennes d’Otorhinolaryngologie et de Pathologie Cervico-faciale. Materiel et methodes Revue systematique des articles scientifiques, consecutivement soumis et acceptes au decours de la periode janvier 2016 - fevier 2019. Objectif principal Description de l’utilisation de la valeur de p et des termes « significatif », « non significatif » et « suggestif » dans le resume. Objectifs secondaires Etude analytique recherchant : (i) un lien statistique entre la mention d’une valeur de p dans le resume et les caracteristiques des auteurs et des sujets traites, (ii) une utilisation inadaptee des termes « significatif », « non significatif » et « suggestif » (compte-tenu des valeurs de p mentionnees) et un lien statistique avec les caracteristiques des auteurs et des sujets traites. Resultats Au total, 91 articles etaient inclus. La valeur de p et les termes « significatif », « non significatif », « suggestif » etaient mentionnes, respectivement, dans 35,1 %, 41,7 %, 10,9 % et 0 % des resumes. La mention d’une valeur de p n’etait pas statistiquement liee aux caracteristiques des auteurs et des sujets traites. Une utilisation inadaptee, detaillee dans le corps de l’article, des termes « significatif », « non significatif » et « suggestif » etait notee dans 57,1, % des resumes avec 30,7 % de sur evaluation et 25,2 % de sous evaluation des resultats, sans lien statistique avec les caracteristiques des auteurs et des sujets traites. Conclusion Auteurs, redacteurs et relecteurs doivent preter plus d’attention au « spin » qui correspond a l’utilisation inappropriee des termes « significatif », « non significatif », « suggestif » dans le resume des articles soumis aux Annales Europeennes d’Otorhinolaryngologie et de Pathologie Cervico-faciale, afin d’ameliorer la rigueur, la qualite et la valeur de l’information scientifique fournie aux lecteurs.
- Published
- 2019
- Full Text
- View/download PDF
5. 694P Prognostic impact of facial nerve resection in patients treated for a primary parotid cancer abutting the facial nerve without preoperative paralysis: A multicentric study of the REFCOR group with propensity score matching analysis
- Author
-
F. Chatelet, N. Fakhry, R. Garrel, E. de Monès, N. Saroul, F. Mouawad, J. Thariat, C. Even, V. Costes Martineau, P. Herman, S. Chevret, and B. Verillaud
- Subjects
Oncology ,Hematology - Published
- 2022
- Full Text
- View/download PDF
6. Leucoplasies et dysplasies des cordes vocales. Mise au point par la Société Française de Phoniatrie et de Laryngologie
- Author
-
M. Remacle, E. Uro Coste, V. Costes-Martineau, Virginie Woisard, I. Atallah, R. Garrel, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Hôpital de Rangueil, CHU Toulouse [Toulouse], Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Hôpital Larrey [Toulouse], CHU Grenoble, CCSD, Accord Elsevier, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), and Centre Hospitalier de Luxembourg [Luxembourg] (CHL)
- Subjects
03 medical and health sciences ,[SPI]Engineering Sciences [physics] ,0302 clinical medicine ,Otorhinolaryngology ,[SPI] Engineering Sciences [physics] ,Dysplasie ,030220 oncology & carcinogenesis ,Surgery ,Leucoplasie ,Corde vocale ,030223 otorhinolaryngology ,Hyperplasie épithéliale ,Cancer - Abstract
International audience; Les leucoplasies et dysplasies des cordes vocales sont regroupées sous le nom de lésions épithéliales hyperplasiques du larynx « LEHL ». L’évaluation initiale et le suivi repose sur l’examen optique bénéficiant des apports de l’image en haute définition, de la stroboscopie et du Narrow Band Imaging. Le diagnostic est anatomopathologique avec la nouvelle classification OMS 2017 qui est simplifiée bas grade et haut grade. Statistiquement, le risque de cancérisation est de 20 % dans les 5 à 10 ans qui suivent le diagnostic initial, d’autant plus chez l’homme âgé de plus de 65 ans, mais ce risque est peu prévisible pour un patient donné. Les voies de recherche reposent sur l’étude des critères génétiques de la lésion et la caractérisation du microenvironnement tumoral. Le traitement des LEHL est exclusivement microchirurgical. Son étendue en profondeur est ajustée à l’infiltration de la lésion. Il s’agit d’une maladie chronique qui nécessite un suivi au long cours, qui peut être rendu difficile par la dysphonie résiduelle et les séquelles cordales des microchirurgies antérieures. Ces séquelles chirurgicales doivent être limitées autant que faire se peut par une maitrise du geste microchirurgical et de ses indications. En cas de séquelles, l’utilisation de biomatériaux tels la graisse autologue et l’acide hyaluronique peuvent avoir leur place. Les techniques de bio-ingénierie tissulaire annoncent des résultats prometteurs.
- Published
- 2020
- Full Text
- View/download PDF
7. Vocal-fold leukoplakia and dysplasia. Mini-review by the French Society of Phoniatrics and Laryngology (SFPL)
- Author
-
Virginie Woisard, V. Costes-Martineau, I. Atallah, E. Uro Coste, M. Remacle, R. Garrel, Service d'ORL, Hôpital Gui de Chauliac (CHRU de Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital de Rangueil, CHU Toulouse [Toulouse], Hôpital Gui de Chauliac [Montpellier], Hôpital Larrey [Toulouse], Hôpital la Tronche, and Centre Hospitalier de Luxembourg [Luxembourg] (CHL)
- Subjects
Male ,medicine.medical_specialty ,Dysplasia ,Laryngology ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Vocal Cords ,Mini review ,Laryngeal Diseases ,Lesion ,Narrow Band Imaging ,Otolaryngology ,03 medical and health sciences ,0302 clinical medicine ,Epithelial hyperplasia ,MESH: Laryngeal Diseases ,MESH: Tumor Microenvironment ,Tumor Microenvironment ,medicine ,MESH: Leukoplakia ,MESH: Narrow Band Imaging ,Humans ,MESH: Vocal Cords ,030223 otorhinolaryngology ,Aged ,Leukoplakia ,Phoniatrics ,Cancer ,MESH: Aged ,MESH: Humans ,business.industry ,Vocal folds ,medicine.disease ,MESH: Male ,MESH: Otolaryngology ,3. Good health ,Chronic disease ,medicine.anatomical_structure ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Surgery ,Radiology ,medicine.symptom ,business - Abstract
International audience; Vocal-fold leukoplakia and dysplasia are together designated "epithelial hyperplastic laryngeal lesions" (EHLL). Work-up and follow-up are founded on optical examination with high-definition imaging, stroboscopy and narrow-band imaging. Diagnosis is based on pathology, using the new 2017 WHO classification, dichotomizing "low grade" and "high grade". Statistically, the risk of cancerous progression is 20% within 5 to 10 years of diagnosis, or more in over-65 year-old males; risk for any given patient, however, is unpredictable. Research focuses on the genetic criteria of the lesion and characterization of the tumoral microenvironment. Treatment is exclusively microsurgical. Resection depth is adjusted according to infiltration. EHLL is a chronic disease, necessitating long-term follow-up, which may be hampered by residual dysphonia and surgical sequelae in the vocal folds. Sequelae need to be minimized by good mastery of microsurgical technique and indications. When they occur, biomaterials such as autologous fat and hyaluronic acid can be useful. Tissue bio-engineering is a promising field.
- Published
- 2020
- Full Text
- View/download PDF
8. Evidence of unrestrained beta-cell proliferation and neogenesis in a patient with hyperinsulinemic hypoglycemia after gastric bypass surgery
- Author
-
Jean Buteau, Dominique R. Garrel, and Nidheesh Dadheech
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Gastric Bypass ,Nesidioblastosis ,030209 endocrinology & metabolism ,medicine.disease_cause ,Glucagon ,Article ,Neogenesis ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Endocrinology ,Hyperinsulinism ,Insulin-Secreting Cells ,medicine ,Humans ,Progenitor cell ,Hyperinsulinemic hypoglycemia ,Cell Proliferation ,biology ,Gastric bypass surgery ,business.industry ,medicine.disease ,biology.organism_classification ,Hypoglycemia ,Obesity, Morbid ,3. Good health ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Beta cell ,business ,Pancreas - Abstract
Hyperinsulinemic hypoglycemia syndrome (HIHG) is a rare complication of roux-en-Y gastric bypass surgery. The pathology is associated with an excessive function of pancreatic beta-cells, and requires pancreas resection in patients that are recalcitrant to nutritional and pharmacological interventions. The exact prevalence is not clearly understood and the underlying mechanisms not yet fully characterized. We herein sought to perform histological and molecular examination of pancreatic sections obtained from a patient who developed HIHG as a complication of gastric bypass compared to 3 weight-matched controls. We studied markers of cellular replication and beta-cell differentiation by immunohistochemistry and immunofluorescence. HIHG after gastric bypass was characterized by a profound increase in beta-cell mass. Cellular proliferation was increased in islets and ducts compared to controls, suggesting unrestrained proliferation in HIHG. We also detected beta-cell differentiation markers in duct cells and occasional duct cells displaying both insulin and glucagon immunoreactivity. These histological observations suggest that beta-cell differentiation from ductal progenitor cells could also underly beta-cell mass expansion in HIHG. Altogether, our results can be construed to demonstrate that HIHG after gastric bypass is characterized by abnormal beta-cell mass expansion, resulting from both unrestrained beta-cell replication and neogenesis.
- Published
- 2018
- Full Text
- View/download PDF
9. Disnea laríngea del adulto
- Author
-
Y. Caussé and R Garrel
- Subjects
03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,030223 otorhinolaryngology - Abstract
La disnea laringea es una urgencia otorrinolaringologica frecuente desde el punto de vista tanto terapeutico (restitucion de la via aerea) como diagnostico. Es el reflejo de un aumento de las resistencias al flujo de aire en la via respiratoria al nivel de la laringe, organo de pequeno calibre. El diagnostico positivo se realiza por la demostracion de la triada sintomatica: bradipnea inspiratoria con tiraje y ruido inspiratorio laringeo (cornaje, estridor), lo que permite distinguirla de otras disneas. El diagnostico etiologico se basa esencialmente en el contexto (traumatico, infeccioso, intoxicacion, mixto) y las caracteristicas de aparicion de la disnea (aguda, progresiva). La etiologia es variada, organica o funcional, intrinseca o extrinseca, al nivel de una o de varias regiones de la laringe (subglotis, glotis y/o supraglotis). En caso de disnea laringea aguda, la busqueda de signos de gravedad se realiza a la vez que la de las circunstancias de aparicion. De este modo, los distintos cuadros caracteristicos dan lugar a un diagnostico y un tratamiento practico en funcion del grado de urgencia. El diagnostico etiologico se respalda con la exploracion fisica ORL, en la que la exploracion nasofibroendoscopica puede completarse con una endoscopia de las vias aerodigestivas superiores y pruebas complementarias en funcion de las etiologias sospechadas y del contexto.
- Published
- 2018
- Full Text
- View/download PDF
10. Traitement par iode 131 des cancers thyroïdiens différenciés : recommandations 2017 des sociétés françaises SFMN/SFE/SFP/SFBC/AFCE/SFORL
- Author
-
Anne-Laure Giraudet, Stéphane Bardet, Slimane Zerdoud, P.-J. Lamy, Jérôme Clerc, A. Al Ghuzlan, Isabelle Keller, Sophie Leboulleux, M E Toubert, F. Sebag, R. Garrel, Laurence Leenhardt, Claire Bournaud, Elif Hindié, Eric Mirallié, Lionel Groussin, and David Taïeb
- Subjects
Gynecology ,medicine.medical_specialty ,Iodine therapy ,Radiological and Ultrasound Technology ,medicine.medical_treatment ,Biophysics ,030209 endocrinology & metabolism ,Biology ,medicine.disease ,Endocrine surgery ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Head and neck surgery ,medicine ,Radiology, Nuclear Medicine and imaging ,Thyroid cancer - Published
- 2017
- Full Text
- View/download PDF
11. Imagerie moléculaire et biomarqueurs des cancers thyroïdiens de souche vésiculaire : recommandations 2017 de SFMN/SFE/SFP/SFBC/AFCE/SFORL
- Author
-
R. Garrel, Slimane Zerdoud, David Taïeb, Isabelle Keller, M E Toubert, Claire Bournaud, Jérôme Clerc, Elif Hindié, F. Sebag, Lionel Groussin, Anne-Laure Giraudet, A. Al Ghuzlan, Stéphane Bardet, P.-J. Lamy, Laurence Leenhardt, Sophie Leboulleux, and Eric Mirallié
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Radiological and Ultrasound Technology ,business.industry ,030220 oncology & carcinogenesis ,Biophysics ,Medicine ,030209 endocrinology & metabolism ,Radiology, Nuclear Medicine and imaging ,business - Published
- 2017
- Full Text
- View/download PDF
12. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France
- Author
-
A. Moya-Plana, A. Aupérin, R. Obongo, A. Baglin, F.R. Ferrand, B. Baujat, N. Saroul, O. Casiraghi, S. Vergez, P. Herman, F. Janot, J. Thariat, B. Vérillaud, L. de Gabory, S. Albert, G. Andry, E. Babin, C. Bach, J.-M. Badet, C. Badoual, A.C. Baglin, A. Banal, B. Barry, E. Baudin, R.J. Bensadoun, C. Bertolus, J.-P. Bessède, D. Blanchard, C. Borel, A. Bozorg-Grayeli, R. Breheret, P. Breton, L. Brugel, G. Calais, E. Cassagnau, L. Castillo, P. Ceruse, F. Chabolle, D. Chevalier, J.C. Chobaut, O. Choussy, A. Cosmidis, A. Coste, V. Costes, L. Crampette, V. Darrouzet, P. Demez, P. Dessi, B. Devauchelle, L. Digue, G. Dolivet, F. Dubrulle, S. Duflo, X. Dufour, C. Even, S. Faivre, N. Fakhry, C. Ferron, F. Floret, R. Garrel, L. Geoffrois, L. Gilain, A. Giovanni, A. Girod, B. Guerrier, S. Hans, P. Hofman, M. Housset, R. Jankowski, F. Jegoux, M. Juliéron, M.-C. Kaminsky, F. Kolb, J. Lacau St Guily, L. Laccoureye, B. Lallemant, P. Lang, E. Lartigau, J.-P. Lavieille, M. Lefevre, X. Leroy, O. Malard, F. Massip, O. Mauvais, J.-C. Merol, J. Michel, T. Mom, S. Morinière, E. de Monès, G. Moulin, G. Noel, G. Poissonnet, J.-M. Prades, D. de Raucourt, E. Reyt, C. Righini, Y. Marie Robin, F. Rolland, B. Ruhin, N. Sarroul, P. Schultz, E. Serrano, O. Sterkers, V. Strunski, A. Sudaka, M. Tassart, S. Testelin, A. Timochenko, B. Toussaint, E. Uro Coste, G. Valette, T. Van den Abbeele, A. Varoquaux, F. Veillon, M. Wassef, Institut Gustave Roussy (IGR), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Département de cancérologie cervico-faciale [Gustave Roussy] (CCF), Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Clermont-Ferrand, Laboratorium für Physikalische Chemie (ETH-LPC), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), French Rare Head and Neck Cancer Expert Network (REFCOR), Service d'Oto-Rhino-Laryngologie (O.R.L.) et de Chirurgie Cervico-Faciale [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), French Rare Head and Neck Cancer Expert Network. (REFCOR), Laboratoire d'études spatiales et d'instrumentation en astrophysique (LESIA), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Service d'ORL et de Chirurgie Cervico-Faciale (PARIS - BICHAT - ORL et CCF), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Médecine nucléaire, Département d'imagerie médicale [Gustave Roussy], Service d’ORL et de chirurgie cervico-faciale [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Paul Strauss de Lutte contre le Cancer (Strasbourg), Génétique, immunothérapie, chimie et cancer (GICC), UMR 6239 CNRS [2008-2011] (GICC UMR 6239 CNRS), Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), Chambre Régionale d'Agriculture des Pays de la Loire, Service de chirurgie, Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Service d’Otorhinolaryngologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Service d'ORL, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS), Département de chirurgie maxillofaciale et stomatologie [CHU d'Amiens-Picardie], CHU Amiens-Picardie, Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER, Service de Radiologie (LILLE - Radio), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service de médecine gériatrique, CHU de Saint-Etienne, Université Paris 13 (UP13), Hôpital Pellegrin, Service d'ORL et chirurgie cervico-faciale, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service d'ORL et Chirurgie Cervico-Facial, Hôpital de la Timone [CHU - APHM] (TIMONE), Fluides, automatique, systèmes thermiques (FAST), Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Laboratoire Géomatériaux (DGCB-LGM), École Nationale des Travaux Publics de l'État (ENTPE)-Centre National de la Recherche Scientifique (CNRS), Neurobiologie des réseaux sensorimoteurs (NRS (U7060)), Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Centre National de la Recherche Scientifique (CNRS), Centre méditérannéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CHU Pontchaillou [Rennes], Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), University of St Andrews [Scotland], Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER, Centre hospitalier universitaire de Nantes (CHU Nantes), Statistique en grande dimension pour la génomique, Département PEGASE [LBBE] (PEGASE), Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Reims (CHU Reims), Institut d'Electronique du Solide et des Systèmes (InESS), Centre National de la Recherche Scientifique (CNRS), Service d'ORL et de Chirurgie Cervico-Faciale (TOURS - ORL et CCF), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Université de Rennes (UNIV-RENNES), Service de chirurgie oncologique cervico-faciale [centre Antoine Lacassagne, Nice], Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA)-UNICANCER-Université Côte d'Azur (UCA), Department of Otolaryngology and Head and Neck Surgery, University Hospital of Grenoble, BP 217, 38043, Grenoble Cedex 09, France, Université Joseph Fourier - Grenoble 1 (UJF), Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF), CRLCC René Gauducheau, CHU Strasbourg-Hôpital de Hautepierre [Strasbourg], Réhabilitation Chirurgicale mini-Invasive et Robotisée de l'Audition, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de cristallographie et sciences des matériaux (CRISMAT), École Nationale Supérieure d'Ingénieurs de Caen (ENSICAEN), Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS)-Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Institut de Chimie du CNRS (INC), Department of Head and Neck Surgery, Hôpital Larrey [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Service d'oto-rhino-laryngologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Biomécanique et génie biomédical (BIM), Réseau d’Expertise Français sur les Cancers ORL Rares - French Network of Rare Head and Neck Tumors (REFCOR), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Groupe innovation et ciblage cellulaire (GICC), EA 7501 [2018-...] (GICC EA 7501), Université de Tours (UT), Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Université Nice Sophia Antipolis (1965 - 2019) (UNS), Université de Lille-UNICANCER, Université de Rennes (UR), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Normandie Université (NU)-Normandie Université (NU)-École Nationale Supérieure d'Ingénieurs de Caen (ENSICAEN), Normandie Université (NU)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche sur les Matériaux Avancés (IRMA), Normandie Université (NU)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Rouen Normandie (UNIROUEN), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS), Les Hôpitaux Universitaires de Strasbourg (HUS), Service Chirurgie maxillo-faciale et plastique de la face [CHU Toulouse], Pôle Céphalique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université de Tours-Centre National de la Recherche Scientifique (CNRS), and Assistance Publique - Hôpitaux de Marseille (APHM)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Oncology ,Male ,Cancer Research ,Multivariate analysis ,medicine.medical_treatment ,0302 clinical medicine ,Paranasal Sinuses ,Medicine ,Prospective Studies ,Stage (cooking) ,Head and neck ,Lymph node ,Melanoma ,Aged, 80 and over ,Mucosal melanoma ,Middle Aged ,Prognosis ,Progression-Free Survival ,3. Good health ,Tumor Burden ,Survival Rate ,medicine.anatomical_structure ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Female ,Mouth Neoplasms ,France ,Algorithms ,Paranasal Sinus Neoplasms ,Adult ,medicine.medical_specialty ,Nose Neoplasms ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,03 medical and health sciences ,Young Adult ,Internal medicine ,Humans ,Sinonasal ,Aged ,Neoplasm Staging ,Radiotherapy ,business.industry ,Head and neck cancer ,Mouth Mucosa ,medicine.disease ,Otorhinolaryngologic Surgical Procedures ,Oral cavity ,Radiation therapy ,Nasal Mucosa ,030104 developmental biology ,Oral Cavity Mucosal Melanoma ,Radiotherapy, Adjuvant ,business - Abstract
International audience; BACKGROUND:Head and neck mucosal melanoma (HNMM) is aggressive and rare, with a poor prognosis because of its high metastatic potential. The two main subtypes are sinonasal (sinonasal mucosal melanoma [SNMM]) and oral cavity (oral cavity mucosal melanoma [OCMM]). Consensual therapeutic guidelines considering the primary tumour site and tumour-node-metastasis (TNM) stage are not well established.MATERIAL & METHODS:Patients with HNMM from the prospective national French Rare Head and Neck Cancer Expert Network database between 2000 and 2017 were included. Clinical characteristics, treatment modalities, outcomes and prognostic factors were analysed.RESULTS:In total, 314 patients were included. The 5-year overall survival (OS) and progression-free survival (PFS) rates were 49.4% and 24.7%, respectively, in the surgery group; no long-term survivors were observed when surgery was not feasible. Moreover, even after surgery, a high recurrence rate was reported with a median PFS of 22 months. In multivariate analysis, Union for International Cancer Control (UICC) stage and tumour site correlated with PFS and OS. Postoperative radiotherapy (PORT) improved the PFS but not OS in patients with small (T3) SNMM and OCMM tumours. Nodal involvement was more frequent in patients with OCMM (p < 10-4), although, as in SNMM, it was not a significant prognostic predictor.CONCLUSION:Even early HNMM was associated with poor oncologic outcomes due to distant metastases despite surgical resection with clear margins. Lymph node metastases had no impact on the prognosis, suggesting treatment de-escalation in cervical node management. PORT might be useful for local control.
- Published
- 2019
- Full Text
- View/download PDF
13. Analyse des cas cliniques soumis aux European Annals of Otorhinolaryngology Head & Neck Diseases
- Author
-
A. Karkas, F. Denoyelle, O. Laccourreye, R. Garrel, C. Martin, R. Jankowski, P. Bonfils, C. Righini, C. Vincent, and M. Makeieff
- Subjects
03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Annals ,030228 respiratory system ,Otorhinolaryngology ,Philosophy ,medicine ,Head neck ,Surgery ,030223 otorhinolaryngology ,Humanities - Abstract
Resume Objectifs Evaluer les defauts, le taux d’acceptation et les raisons du rejet des cas cliniques soumis pour publication aux European Annals of Otorhinolaryngology Head & Neck Diseases . Materiel et methodes Etude prospective realisee a partir de la relecture de 118 cas cliniques provenant de 29 pays consecutivement soumis aux European Annals of Otorhinolaryngology Head & Neck Diseases au decours de la periode 01/09/2014–31/09/2015. Resultats Les principaux defauts, notes dans 74,5 % des cas, lors de la relecture etaient l’absence d’originalite (plus de 15 cas cliniques identiques au cas soumis deja publies dans la litterature medicale) et l’absence d’apport de donnees nouvelles a la litterature medicale scientifique publiee sur le sujet. Apres relecture, 5 % des cas cliniques etaient acceptes, 7 % n’etaient pas re-adresses a la revue par les auteurs et 88 % etaient rejetes. En analyse monovariee, aucun lien statistique n’apparaissait entre l’acceptation ou le refus des cas cliniques et les variables analysees. Le delai pour accepter ou non l’article soumis a la revue variait de 1 a 7 mois avec une mediane a 1 mois. Au sein de 104 cas cliniques rejetes, les editeurs proposaient aux auteurs de re-soumettre leur travail dans les rubriques « lettre a l’editeur » ou « quel est votre diagnostic ? », dans 16,3 % des cas (17/104). Quinze de ces dix-sept travaux etaient re-adresses et dix (66,6 %) d’entre eux etaient acceptes apres relecture. Conclusion Le comite editorial des European Annals of Otorhinolaryngology Head & Neck Diseases espere que les donnees presentees ainsi que l’analyse de la litterature consacree a ce sujet fourniront aux auteurs une trame qui leur permettra d’eviter les erreurs qui conduisent au rejet de leur article et facilitera la publication rapide des cas cliniques qu’ils soumettront a notre revue, dans le futur.
- Published
- 2016
- Full Text
- View/download PDF
14. Characteristics and analysis of scientific articles submitted to the European Annals of Otorhinolaryngology, Head and Neck Diseases
- Author
-
C. Vincent, M. Makeieff, C. Righini, O. Laccourreye, R. Garrel, A. Karkas, F. Denoyelle, P. Bonfils, C. Martin, R. Jankowski, Service d'ORL et chirurgie cervico-faciale, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), and Université de Montpellier (UM)
- Subjects
medicine.medical_specialty ,Writing ,Guidelines as Topic ,Medical writing ,Otolaryngology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Statistical analysis ,Medical physics ,Prospective Studies ,[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs ,030223 otorhinolaryngology ,Head and neck ,Publishing ,business.industry ,Spelling ,3. Good health ,Surgery ,Annals ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Head and neck surgery ,Periodicals as Topic ,business ,Scientific report - Abstract
Objectives To evaluate characteristics, suggested modifications and reasons for rejection in scientific articles submitted for publication in the European Annals of Otorhinolaryngology, Head and Neck Diseases. Materials and methods A prospective study analyzed the flaws noted by reviewers in 52 scientific articles submitted to the European Annals of Otorhinolaryngology, Head and Neck Diseases between August 31, 2014 and February 28, 2015. Results Fifteen flaws concerning content and 7 concerning form were identified. In more than 25% of submissions, major flaws were noted: purely descriptive paper; lack of contribution to existing state of knowledge; failure to define a clear study objective and/or analyze the impact of major variables; poorly structured Materials and methods section, lacking description of study population, objective and/or variables; lack of or inappropriate statistical analysis; Introduction verbose and/or misrepresenting the literature; excessively heterogeneous and/or poorly described study population; imprecise discussion, straying from the point, overstating the significance of results and/or introducing new results not mentioned in the Results section; description of the study population placed in the Results section instead of under Materials and methods; serious mistakes of syntax, spelling and/or tense; and failure to follow the Instructions to Authors. After review, 21.1% of articles were published, 65.3% rejected and 13.4% non-resubmitted within 3 months of review. On univariate analysis, the only variable increasing the percentage of articles accepted was the topic not being devoted to head and neck surgery (P = 0.03). Conclusion These results document the excessive flaw rate still to be found in manuscripts and demonstrate the continuing need for authors to master and implement the rules of scientific medical writing.
- Published
- 2015
- Full Text
- View/download PDF
15. Caractéristiques et analyse des articles scientifiques soumis aux European Annals of Otorhinolaryngology, Head & Neck Diseases
- Author
-
C. Righini, P. Bonfils, F. Denoyelle, O. Laccourreye, C. Vincent, R. Jankowsk, R. Garrel, A. Karkas, C. Martin, and M. Makeieff
- Subjects
medicine.medical_specialty ,Annals ,Otorhinolaryngology ,Philosophy ,medicine ,Head neck ,Surgery ,Humanities - Abstract
Resume Objectifs Evaluer les caracteristiques, les defauts et les raisons du rejet des articles scientifiques soumis pour publication aux European Annals of Otorhinolaryngology, Head & Neck Diseases. Materiel et methodes Etude prospective realisee a partir de la relecture de 52 articles scientifiques soumis aux European Annals of Otorhinolaryngology, Head & Neck Diseases au decours de la periode 31/08/2014–28/02/2015. Resultats Quinze types de defauts ayant trait au fond et sept ayant trait a la forme de l’article etaient identifies. Dans plus de 25 % des cas un defaut majeur (caractere purement descriptif de l’etude, absence d’apport aux donnees et publications deja existantes, non-definition d’un but precis et/ou absence d’etude de l’impact de variables majeures, chapitre materiel et methodes mal structure ne presentant pas la population etudiee et/ou le but de l’etude et/ou les variables analysees, absence d’analyse statistique et/ou tests statistiques incorrects, introduction vague, trop longue et/ou ne refletant pas la litterature, population analysee trop heterogene et/ou mal definie, discussion vague, hors sujet, surevaluant les resultats, sans rapport avec le but de l’etude ou les resultats et/ou presentant de nouveaux resultats, description de la population etudiee placee dans le chapitre resultat et non dans le chapitre materiel et methodes, existence de problemes majeurs de syntaxe, d’orthographe et/ou de temps des verbes, non-respect des conseils aux auteurs de la revue) etait note. Apres relecture, 21,1 % des articles etaient acceptes, 65,3 % etaient rejetes et 13,4 % n’etaient pas re-adresses a la revue par les auteurs trois mois apres la relecture. En analyse monovariee, seule la thematique non cervico-faciale augmentait le pourcentage d’articles acceptes (p = 0,03). Conclusion Cette etude souligne que le nombre d’auteurs qui meconnaissent et/ou ne respectent pas les regles de la redaction d’un article scientifique reste eleve.
- Published
- 2015
- Full Text
- View/download PDF
16. A RandomizEd trial of ENtERal Glutamine to minimIZE thermal injury (The RE-ENERGIZE Trial): a clinical trial protocol
- Author
-
Dominique R. Garrel, Alexis F. Turgeon, Marc G. Jeschke, Daren K. Heyland, Paul E. Wischmeyer, Lucy Wibbenmeyer, Henry T. Stelfox, and Andrew G. Day
- Subjects
medicine.medical_specialty ,Burn injury ,lcsh:Surgery ,Energy Engineering and Power Technology ,Management Science and Operations Research ,randomized trials ,Enteral administration ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,medicine ,lcsh:Dermatology ,Severe burn ,030212 general & internal medicine ,Intensive care medicine ,Thermal injury ,business.industry ,Mechanical Engineering ,030208 emergency & critical care medicine ,lcsh:RD1-811 ,lcsh:RL1-803 ,3. Good health ,Clinical trial ,Glutamine ,nutrition support ,Nutrition support ,glutamine ,Original Article ,business - Abstract
Background: Burn injury represents a significant public health problem worldwide. More than in any other injury, the inflammation and catabolism associated with severe burns can exacerbate nutrient deficiencies resulting in impaired immune function and increased risk of developing infection, organ dysfunction and death. Consequently, over the last few decades numerous trials have evaluated the impact of different nutritional strategies in severe burn injury. Glutamine is of particular interest, as it appears vital for a number of key stress-response pathways in serious illness. The purpose of the current manuscript is to provide the rationale and protocol for a large clinical trial of supplemental enteral glutamine in 2700 severe burn-injured patients. Methods: We propose a multicentre, double-blind, pragmatic, randomized, clinical trial involving 80 tertiary intensive care unit (ICU) burn centres worldwide. We aim to enrol patients with deep second- and/or third-degree burns at moderate or high risk for death. We will exclude patients admitted > 72 h before screening and patients with advanced liver and kidney disease. The study intervention consists of enteral glutamine 0.5 g/kg/day vs. isocaloric maltodextran control delivered enterally. Primary outcome will be six-month mortality. Key secondary outcomes include time to discharge alive from hospital, ICU and hospital mortality, length of stay and health-related quality of life at six months. Significance: This study will be the first large international multicentre trial examining the effects of glutamine in burn patients. Negative or positive, the results of this trial will inform the clinical practice of burns care worldwide. Clinicaltrials.gov ID #NCT00985205, Lay Summary Patients with severe burns need to recover in a hospital burn unit for a long time and are at high risk of developing infections and dying. Proper nutrition and certain nutrients may improve survival in these patients and shorten their stay in the burn unit. Glutamine is a building block of protein that is normally made in the body and is found in different foods we eat. It is of great interest because it has several beneficial effects on the body during serious illness, such as with burn injury. In this study, we will look at the effect of glutamine supplementation on survival and time spent in hospital. A total of 80 burn units around the world will enrol 2700 patients with 2nd or 3rd degree burns over 4 years. Patients will receive either glutamine powder or a placebo through a feeding tube or mixed with food, from admission to the burn unit, until a week after the burn wound has healed. The main outcome for this study is survival at 6 months. Other outcomes include the time taken to be discharged from hospital alive and duration of stay in the burn unit. This study will be the first large international multicentre trial examining the effects of glutamine in burn patients. Glutamine may lead to better survival and less complications in burn patients, who have a devastating and disabling burn injury. If the trial is positive, the results will be used to inform how nutrition should be given to such patients worldwide.
- Published
- 2017
17. Monitoraggio intraoperatorio in chirurgia otorinolaringoiatrica
- Author
-
Frédéric Venail, A Uziel, R Garrel, and C Cartier
- Abstract
Il monitoraggio puo essere definito dall’insieme delle tecniche che permettono di fornire al chirurgo un’informazione sulla funzione di un nervo cranico durante un intervento chirurgico. Esso e divenuto in questi ultimi anni uno strumento di aiuto nella chirurgia otorinolaringoiatrica, in particolare nella chirurgia cervicale, otologica o della base del cranio. Questa tecnica e stata inizialmente sviluppata per il monitoraggio della funzione facciale durante la chirurgia dello schwannoma vestibolare, poi si e ampliata ai settori della chirurgia dell’orecchio medio, della parotide e della tiroide. Essa permette di aiutare il chirurgo a individuare le strutture nervose, ma, soprattutto, di avvertirlo mediante un allarme ogni volta che il suo gesto e traumatizzante per il nervo. Parallelamente si sono sviluppate delle tecniche elettrofisiologiche di monitoraggio dell’attivita del nervo cocleare che, benche non scatenino un allarme in tempo reale, forniscono delle informazioni durante l’intervento sulla funzione uditiva e consentono di stabilire una prognosi sulla conservazione dell’udito al termine dell’intervento. Attraverso questo articolo, spiegheremo in dettaglio i metodi che permettono il monitoraggio motorio e sensoriale dei nervi della base del cranio, dalla loro origine fino al loro tragitto extracranico. Preciseremo le indicazioni del monitoraggio dei nervi nella chirurgia della base del cranio, in chirurgia otologica e in chirurgia cervicale, specificando i risultati attesi, ma anche e soprattutto i limiti di questi metodi, di cui il medico deve essere pienamente cosciente.
- Published
- 2013
- Full Text
- View/download PDF
18. Les adénocarcinomes nasosinusiens revisités. Intérêt pronostique de la classification histologique OMS 2005
- Author
-
F. Poizat, M. Kzadri, A. El Ayoubi, R. Garrel, Leila Essakalli, L. Crampette, V. Costes, and Bernard Guerrier
- Subjects
Gynecology ,medicine.medical_specialty ,Otorhinolaryngology ,business.industry ,Medicine ,Surgery ,business - Abstract
Resume Objectifs La classification histologique OMS 2005 propose de demembrer les adenocarcinomes nasosinusiens (ADK) en trois classes : intestinal type adenocarcinomas (ITAC), les bas grades et les hauts grades. Le but de cette etude etait de verifier la pertinence de ce classement sur le pronostic de patients traites pour ADK. Patients et methodes Tous les dossiers de patients traites consecutivement dans le service d’ORL du CHU de Montpellier pour ADK entre 1980 et 2003 ont ete retrospectivement revus. Chaque cas a beneficie d’une relecture anatomopathologique en se basant sur l’immunohistochimie conformement a la classification OMS 2005 en etudiant un panel de marqueurs : cytokeratine 7 (CK7), cytokeratine 20 (CK20), Villin, CDX2, EGFR. Les donnees epidemiologiques, les modalites de traitement et le suivi ont ete etudies. Les probabilites de survie ont ete calculees par la methode de Kaplan-Meier et la comparaison des courbes de survie par le test de log-rank. Resultats Soixante-deux dossiers ont ete colliges. Douze cas ont ete reclasses en carcinomes adenoides kystiques et exclus de l’etude. Sur les 50 cas restants, il y avait 36 ITAC, quatre ADK de bas grade et dix ADK de haut grade. Pour l’ensemble des ADK, la survie globale a cinq ans et sans recidive etaient respectivement de 64 et 52 %. L’analyse des trois sous-groupes d’ADK montre une survie globale a cinq ans de 72,2 % pour les ITAC, 100 % pour les bas grades et 20 % pour les hauts grades avec une difference significative (p = 0,044). Cette distinction sur le plan immunohistochimique est principalement basee sur l’expression de CK20 retrouvee dans 98 % des ITAC et absente dans les bas grades et les hauts grades. Conclusion La classification OMS 2005 des ADK nasosinusiens revet un interet pronostique en montrant une difference de profil evolutif entre les ITAC, les ADK de bas grade et de haut grade. De plus larges etudes sont souhaitables afin d’etudier le pronostic des differents sous-types d’ITAC.
- Published
- 2009
- Full Text
- View/download PDF
19. Validation of the newborn larynx modeling with aerodynamical experimental data
- Author
-
Maurice Ouaknine, Jérome Giordano, Jean-Michel Triglia, Richard Nicollas, P. Caminat, Antoine Giovanni, Marc Medale, and R. Garrel
- Subjects
Larynx ,Validation study ,Computer science ,Air ,Acoustics ,Infant, Newborn ,Biomedical Engineering ,Biophysics ,Infant ,Experimental data ,Laser Doppler velocimetry ,Voice production ,Models, Biological ,Fetus ,medicine.anatomical_structure ,Particle image velocimetry ,Vocal folds ,Pressure ,medicine ,Fluent ,Humans - Abstract
Background Many authors have studied adult’s larynx modelization, but the mechanisms of newborn’s voice production have very rarely been investigated. After validating a numerical model with acoustic data, studies were performed on larynges of human fetuses in order to validate this model with aerodynamical experiments. Material and methods Anatomical measurements were performed and a simplified numerical model was built using Fluent ® with the vocal folds in phonatory position. The results obtained are in good agreement with those obtained by laser Doppler velocimetry (LDV) and high-frame rate particle image velocimetry (HFR-PIV), on an experimental bench with excised human fetus larynges. Results It appears that computing with first cry physiological parameters leads to a model which is close to those obtained in experiments with real organs.
- Published
- 2009
- Full Text
- View/download PDF
20. Kystes du larynx et laryngocèles
- Author
-
B. Guerrier, Michel Mondain, and R. Garrel
- Subjects
business.industry ,Medicine ,Anatomy ,business - Published
- 2009
- Full Text
- View/download PDF
21. Cisti della laringe e laringocele
- Author
-
B. Guerrier, R. Garrel, and M. Mondain
- Subjects
Physics ,Humanities - Abstract
Le cisti della laringe e i laringoceli formano un’entita nosologica eterogenea. La componente principale di queste patologie si sviluppa a spese del ventricolo laringeo, o ventricolo di Morgani, e della sua appendice anteriore, il sacculo. Si tratta di cisti sacculari, di laringoceli, di laringomucoceli e di laringopioceli. Il secondo quadro nosologico e rappresentato dalle cisti da inclusione o da ritenzione ghiandolare, che possono coinvolgere qualsiasi piano laringeo. Infine, si possono riscontrare alcune cisti estremamente rare per l’alterazione dello sviluppo embrionale, che conduce ad anomalie della cartilagine tiroide, alla cisti foraminale e alla duplicazione cistica della laringe. La sintomatologia dipende dall’eta di insorgenza, dalla sede e dal volume della cisti e da un’eventuale sovrainfezione. Numerose cisti sono asintomatiche. Viceversa, alcuni casi sono rivelati da una dispnea acuta minacciosa in un contesto talvolta infettivo. La terapia, al di fuori dell’urgenza, si basa sulla resezione endoscopica laser o, in sua mancanza, sulla marsupializzazione. Quando e presente un contingente extralaringeo predominante, questo e aggredito per via esterna. La terapia chirurgica adeguata offre buone possibilita di guarigione, ma le recidive sono sempre possibili, imponendo, allora, la realizzazione di procedure ripetute.
- Published
- 2009
- Full Text
- View/download PDF
22. Quistes de la laringe y laringoceles
- Author
-
M. Mondain, B. Guerrier, and R. Garrel
- Subjects
General Medicine - Abstract
Los quistes de la laringe y los laringoceles constituyen una entidad nosologica heterogenea. El componente principal de estas afecciones se desarrolla a expensas del ventriculo laringeo o ventriculo de Morgani y de su apendice anterior, el saculo. Se trata de los quistes saculares, los laringoceles, los laringomucoceles y los laringopioceles. El segundo cuadro nosologico esta constituido por los quistes de inclusion o de retencion glandular, que pueden afectar a cualquier tramo laringeo. Por ultimo, algunos quistes muy infrecuentes pueden aparecer por anomalias del desarrollo embrionario que dan lugar a malformaciones del cartilago tiroides: quiste foraminal y duplicacion quistica de la laringe. La sintomatologia depende de la edad de aparicion, de la localizacion y del volumen del quiste, asi como de una posible sobreinfeccion. Muchos quistes son asintomaticos. Por el contrario, algunos casos se ponen de manifiesto por una disnea aguda potencialmente mortal en un contexto en ocasiones infeccioso. El tratamiento, fuera de la fase urgente, consiste en la reseccion endoscopica con laser o, en su defecto, en la marsupializacion. Cuando existe un componente extralaringeo predominante, este se trata por via externa. El tratamiento quirurgico adecuado ofrece buenas posibilidades de curacion, pero las recidivas siempre son posibles, lo que obliga a realizar intervenciones repetidas.
- Published
- 2009
- Full Text
- View/download PDF
23. An unusual succinate dehydrogenase gene mutation C in a case of laryngeal paraganglioma
- Author
-
P Raynaud, C Muyshondt, Q. Gardiner, R Garrel, I Coupier, P. Pujol, Isabelle Raingeard, and B Guerrier
- Subjects
Adult ,Pathology ,medicine.medical_specialty ,Dehydrogenase ,Gene mutation ,Paraganglioma ,Rare Diseases ,Germline mutation ,Humans ,Medicine ,Genetic Predisposition to Disease ,Laryngeal Neoplasms ,Germ-Line Mutation ,biology ,business.industry ,Succinate dehydrogenase ,Membrane Proteins ,General Medicine ,Laryngeal Neoplasm ,medicine.disease ,Succinate Dehydrogenase ,Otorhinolaryngology ,Laryngeal Paraganglioma ,Mutation (genetic algorithm) ,biology.protein ,Female ,business - Abstract
Objective:To report a rare case of a laryngeal paraganglioma related to succinate dehydrogenase gene mutation C.Method:A case report and a review of the world literature concerning succinate dehydrogenase mutations and laryngeal paraganglioma are presented.Results:We identified a laryngeal paraganglioma in a 38-year-old woman, related to a very rare, deleterious in exon 4 of the succinate dehydrogenase mutation C. This mutation was a non-sense mutation: c.183G >A leading to p.Trp61X. No other neuroendocrine tumour was identified in this case, but a thyroid papillary carcinoma was concomitantly discovered and cured.Conclusion:To our knowledge, this is the first report in the world literature of laryngeal paraganglioma related to a succinate dehydrogenase mutation C. The case presented underlines the fact that every patient with paraganglioma should be tested for succinate dehydrogenase genetic mutations, even if a family history of paraganglioma is absent, in order to enable appropriate clinical management and to improve our knowledge of familial paraganglioma.
- Published
- 2008
- Full Text
- View/download PDF
24. Differential Effect of Burn Injury on Fibroblasts from Wounds and Normal Skin
- Author
-
Dominique R. Garrel, B Nedelec, Michel Saint-Cyr, and Ana de Oliveira
- Subjects
Adult ,Male ,Burn injury ,Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,Dermal fibroblast ,Lesion ,Andrology ,medicine ,Humans ,Fibroblast ,Cell Proliferation ,Skin ,Wound Healing ,integumentary system ,business.industry ,Fibroblasts ,Middle Aged ,In vitro ,medicine.anatomical_structure ,Cytokine ,Cytokines ,Surgery ,medicine.symptom ,Burns ,business ,Normal skin ,Fetal bovine serum - Abstract
Background: Although there are well-recognized fluctuations in the systemic concentration of cytokines and growth factors after burn injuries, the effect on wound-healing potential in patients is not well understood. The objective of this study was to characterize the proliferation rate and response of wound and dermal fibroblasts to cytokines in burn patients compared with normal subjects. Methods: Polyvinyl alcohol sponges were implanted subcutaneously in normal subjects and burn patients soon after admission. Sponges were removed for wound fibroblast explantation after 12 days. At the same time, a small piece of skin was excised for dermal fibroblast explantation. Fibroblast proliferation was then quantified after exposure to 10% fetal bovine serum, 1% fetal bovine serum, interleukin-1, transforming growth factor-β1, or interferon-a2b. Results: Normal subjects' dermal fibroblasts (n = 7) exposed to 10% fetal bovine serum showed significantly increased proliferation relative to normal subjects' wound fibroblasts (n = 3) (p < 0.0005), burn patients' dermal fibroblasts (n = 5) (p < 0.05), and burn patients' wound fibroblasts (n = 5) (p < 0.0001). Burn patients' dermal fibroblast proliferation was also significantly augmented relative to burn patients' wound fibroblasts (p < 0.005); however, there was no significant difference between the two wound fibroblast types. Proliferation of burn subjects' fibroblasts was significantly enhanced with the addition of interleukin-1 and significantly decreased for dermal fibroblasts with interferon-a2b. A significant elevation of proliferation with transforming growth factor-β1 was seen only with burn patients' dermal fibroblasts. Conclusions: The data suggest that systemic mediators markedly alter the proliferation potential of dermal fibroblasts but not of wound fibroblasts. However, the wound environment substantially alters both the proliferation rate and the responsiveness of fibroblasts to cytokines. Thus, the data support the value of using wound fibroblasts during preliminary in vitro experiments to investigate wound-healing modification by cytokine manipulation. (Plast. Reconstr. Surg.
- Published
- 2007
- Full Text
- View/download PDF
25. No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters
- Author
-
Jacques Bernier, Julie Patenaude, Michele D’Elia, Dominique R. Garrel, and Claudine Hamelin
- Subjects
CD4-Positive T-Lymphocytes ,Male ,Hypothalamo-Hypophyseal System ,medicine.medical_specialty ,Globulin ,Ratón ,Blotting, Western ,Immunology ,Pituitary-Adrenal System ,Thymus Gland ,CD8-Positive T-Lymphocytes ,Mice ,Random Allocation ,chemistry.chemical_compound ,Immune system ,Transcortin ,Corticosterone ,Internal medicine ,medicine ,Animals ,Immunology and Allergy ,biology ,Blotting, Northern ,Flow Cytometry ,Buprenorphine ,Analgesics, Opioid ,Mice, Inbred C57BL ,Endocrinology ,Opioid ,chemistry ,biology.protein ,RNA ,Carrier Proteins ,Cell Division ,Spleen ,hormones, hormone substitutes, and hormone antagonists ,Glucocorticoid ,medicine.drug - Abstract
Opioid drugs reportedly regulate the immune system via their effects on the hypothalamic- pituitary-adrenal (HPA) axis. The present study was carried out to assess the effects of chronic exposure to buprenorphine on HPA axis activation, corticosteroid-binding globulin (CBG), the main glucocorticoid (GC) carrier, and the immune system. Results show that buprenorphine, delivered by osmotic pump subcutaneously in C57BL/6 male mice during a 10-day period, caused a marked decrease in total corticosterone (CORT) levels at day 1 of exposure. CORT levels then increased with maximal values observed at day 5 of exposure. After day 5, total CORT levels gradually decreased and returned to control values. No significant changes were observed in CBG protein levels and mRNA expression in the liver. Since CBG levels remained unchanged, the percentage of free CORT values in buprenorphine mice did not differ from control values. Thus, the variations observed in the amount of free CORT were related only to changes measured in total CORT. These endocrine changes did not have a significant impact on the immune parameters measured. Total CD(4)+ and CD(8)+ splenic and thymic populations were not modulated by buprenorphine. However, splenocytes from mice exposed to buprenorphine after 5 days exhibited greater proliferation upon anti-TCR monoclonal antibody stimulation than saline-exposed mice. These results indicate that buprenorphine can be safely used because it did not have significant effects on GC availability for immune corticosensitive cells.
- Published
- 2003
- Full Text
- View/download PDF
26. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial*
- Author
-
Michele D’Elia, Julie Patenaude, Jacques Bernier, Louise Samson, Julie Champoux, Dominique R. Garrel, Judy Dorais, and Bernadette Nedelec
- Subjects
medicine.medical_specialty ,Pediatrics ,business.industry ,Burn center ,Critical Care and Intensive Care Medicine ,Enteral administration ,law.invention ,Clinical trial ,Glutamine ,Parenteral nutrition ,Randomized controlled trial ,law ,Intensive care ,medicine ,Intensive care medicine ,Prospective cohort study ,business - Abstract
Garrel D, Patenaude J, Nedelec B, Samson L, Dorais J, Champoux J, D'Elia M, Bernier J. OBJECTIVE : Enteral glutamine supplements have been shown to reduce infectious morbidity in trauma patients, but their effect on burn patients is not known. The objective of this study was to measure the impact of enteral glutamine supplementation on infectious morbidity, length of care, and the immune system in burn patients. DESIGN : Double-blinded, randomized clinical trial. SETTING : Burn center. (...)
- Published
- 2003
- Full Text
- View/download PDF
27. Acute phase modulation of systemic insulin-like growth factor-1 and its binding proteins after major burn injuries*
- Author
-
Ana de Oliveira, Bernadette Nedelec, and Dominique R. Garrel
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Proteolysis ,Critical Care and Intensive Care Medicine ,Insulin-like growth factor ,In vivo ,Internal medicine ,medicine ,Humans ,Insulin-Like Growth Factor I ,Acute-Phase Reaction ,Aged ,medicine.diagnostic_test ,business.industry ,Burn center ,Radioimmunoassay ,Venous blood ,Metabolism ,Middle Aged ,Pathophysiology ,Insulin-Like Growth Factor Binding Proteins ,Insulin-Like Growth Factor Binding Protein 3 ,Endocrinology ,Case-Control Studies ,Regression Analysis ,Female ,Burns ,business - Abstract
OBJECTIVES To provide a detailed, sequential analysis of insulin-like growth factor-1 and its binding proteins in adults during the acute phase after a major burn injury. DESIGN Descriptive, repeated measurements for quantitation and characterization of insulin-like growth factor-1 and its binding proteins in adult burn survivors. SETTING Burn center in a university hospital. PATIENTS A total of 17 severely burned (>15% total body-surface area burned) adult patients. INTERVENTIONS Venous blood was collected twice a day for 10 days and centrifuged, and the sera were stored at -80 degrees C until analysis. A series of 340 serum samples were analyzed by radioimmunoassay to determine the circulating concentration of insulin-like growth factor-1 and its major binding proteins (insulin-like growth factor-binding protein), by Western ligand blotting. To better understand the changes seen in systemic insulin-like growth factor-binding protein-3 levels by Western ligand blotting, a proteolysis assay was performed. MEASUREMENTS AND MAIN RESULTS Insulin-like growth factor-1 levels were reduced from day 0 and correlated with insulin-like growth factor-binding protein-1 and -2 (p
- Published
- 2003
- Full Text
- View/download PDF
28. Effects of dietary fatty acids on burn-induced immunosuppression
- Author
-
Jacques Bernier, Viviane D Bordé, and Dominique R. Garrel
- Subjects
Lipopolysaccharides ,medicine.medical_specialty ,Burn injury ,Lipopolysaccharide ,medicine.medical_treatment ,Immunology ,Biology ,Lymphocyte Activation ,Nitric Oxide ,medicine.disease_cause ,Nitric oxide ,Mice ,Random Allocation ,chemistry.chemical_compound ,Internal medicine ,Concanavalin A ,Splenocyte ,medicine ,Animals ,Receptor ,Mice, Inbred C3H ,Thermal injury ,Fatty Acids ,Immunosuppression ,Dietary Fats ,Oxidative Stress ,Endocrinology ,chemistry ,Female ,Burns ,Spleen ,Oxidative stress - Abstract
Previous studies from our laboratory established that low-fat diets prevent immunosuppression and reduce oxidative stress after a thermal injury. The purpose of the present study was to test the hypothesis that the type of dietary fatty acid influences splenocyte proliferation and oxidative stress following a burn injury. Female C3H/HeN mice were fed ad libitum six experimental diets (5% w/w lipids) differing in fatty acid composition for 10 days following a burn injury. Compared to the controls, burned mice fed whichever diet showed lower lymphoproliferative responses to concanavalin-A (Con-A) and lipopolysaccharide (LPS) (p
- Published
- 2002
- Full Text
- View/download PDF
29. Increased thermogenic response to food and fat oxidation in female athletes: relationship withV˙<scp>o</scp> 2 max
- Author
-
Marielle Ledoux, Pilar López, and Dominique R. Garrel
- Subjects
Adult ,medicine.medical_specialty ,Adolescent ,Anaerobic Threshold ,Physiology ,Rest ,Endocrinology, Diabetes and Metabolism ,Physical exercise ,Endurance training ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,Glucose tolerance test ,biology ,medicine.diagnostic_test ,Chemistry ,Athletes ,Substrate (chemistry) ,Metabolism ,Glucose Tolerance Test ,biology.organism_classification ,Dietary Fats ,Diet ,Endocrinology ,Adipose Tissue ,Energy expenditure ,Food ,Body Composition ,Exercise Test ,Physical Endurance ,Female ,Oxidation-Reduction ,Thermogenesis ,Body Temperature Regulation - Abstract
The thermogenic response to food (TRF) and substrate oxidation were studied in 12 endurance-trained and 13 untrained female subjects. Energy expenditure and substrate oxidation were calculated by indirect calorimetry before and for 6 h after an oral test meal and after the same meal given intragastrically on a separate occasion. The TRF was calculated after the oral meal, the obligatory component after the intragastric meal (OTRF), and the facultative component from the difference between the two. V˙o 2 max was measured on a treadmill and body composition by underwater weighing. The TRF and OTRF were significantly higher in trained than in untrained subjects: 223 ± 63 vs. 185 ± 50 kJ/6 h ( P< 0.03) and 174 ± 38 vs. 131 ± 37 kJ/6 h ( P < 0.01) for the TRF and OTRF in trained vs. untrained subjects, respectively. Multiple regression analysis showed that maximum O2 consumption (V˙o 2 max), but not percentage of body fat, was significantly related to OTRF ( r =0.68, P < 0.01). Trained subjects had higher fatty acid oxidation than untrained subjects before (0.6 vs. 0.4 mg · kg−1 · min−1, P < 0.05) and after the oral meal (13 ± 6 vs. 8 ± 4 g/6 h P < 0.05). These results demonstrate that 1) TRF is higher in trained than in untrained women; 2) this is due to a higher cost of nutrient digestion, absorption and storage; 3) the difference is related to higher V˙o 2 max; and 4) fatty acid oxidation is greater in trained women in both the postabsorptive and postprandial states. These observations suggest that endurance training induces metabolic changes that favor leanness.
- Published
- 2000
- Full Text
- View/download PDF
30. Decreased serum insulin-like growth factor-I in burn patients: Relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support
- Author
-
Dominique R. Garrel, Bernadette Nedelec, Thierry Abribat, and Nathalie Jobin
- Subjects
Adult ,Male ,Parenteral Nutrition ,medicine.medical_specialty ,Proteolysis ,medicine.medical_treatment ,Burn Units ,Radioimmunoassay ,Critical Care and Intensive Care Medicine ,Enteral administration ,Enteral Nutrition ,Injury Severity Score ,Double-Blind Method ,Intensive care ,Internal medicine ,Fatty Acids, Omega-3 ,medicine ,Humans ,Insulin-Like Growth Factor I ,medicine.diagnostic_test ,business.industry ,Growth factor ,Binding protein ,Methylhistidines ,Dietary Fats ,Pathophysiology ,Insulin-Like Growth Factor Binding Protein 3 ,Endocrinology ,Parenteral nutrition ,Female ,Burns ,business - Abstract
To test the effects of the amount and type of fat in the nutritional support on serum insulin-like growth factor (IGF)-I concentrations in burn patients and to test the hypothesis that the serum proteolytic activity for insulin-like growth factor binding protein (IGFBP)-3 is a major mechanism for the decreased serum IGF-I observed in these patients.Randomized, double-blind trial of three different nutritional supports and analysis of serum IGF-I, IGFBP-3, and serum IGFBP-3 proteolysis.Burn center in a university hospital.A total of 23 severely burned (25% total body surface area burned) adult patients.Patients were randomly assigned to three types of nutritional support differing in the amount of energy derived from fat and the presence or absence of fish oil: Group I (control), 35% fat; Group II, 15% fat; Group III, 15% fat with 50% as fish oil. Nutritional support was both parenteral and enteral and was started within 24 hrs of admission.Serum IGF-I and IGFBP-3 were measured by radioimmunoassay every 3 days for 28 days in 23 severely burned adults. In six patients, IGFBP-3 was measured by ligand binding assay and the serum proteolytic activity for rhIGFBP-3 was measured as well. Serum IGF-I concentration was low in all subjects throughout the study period, but did increase with time (p.01); significantly higher values were found in Group III (p.05). Multivariate analysis showed that fish oil and low fat solutions were significantly correlated to serum IGF-I concentrations. Serum IGFBP-3 (radioimmunoassay) was higher than normal throughout the study with no difference between the groups. Between days 4 and 16, IGFBP-3 was cleaved into two fragments in all patients studied, and the molecular weights of the fragments were equal to those observed in the serum of a woman late in pregnancy. During this period of time, serum proteolytic activity for rhIGFBP-3 was30% in 24 of the 30 samples measured, whereas 20 of the 28 samples measured thereafter were normal (25%). Serum IGFBP-3 concentration from ligand binding assay was correlated with serum proteolytic capacity in all subjects (mean r2 = 0.77; p.01) and with serum IGF-I concentrations in five of six subjects (mean r2 = 0.81; p.01).In burn injury, serum IGF-I concentrations are sensitive to the amount and type of fat in their nutritional support. The presence of fish oil allowed for a more rapid recovery of serum IGF-I levels. The proteolysis of IGFBP-3 may be an important cause of the decreased serum IGF-I values and the protease(s) responsible for this seem to be similar to those observed in late pregnancy.
- Published
- 2000
- Full Text
- View/download PDF
31. Decreased corticosteroid-binding globulin in burn patients
- Author
-
Dominique R. Garrel, Nathalie Jobin, Michel Pugeat, Agnès Emptoz-Bonneton, and Jacques Bernier
- Subjects
Adult ,Male ,Parenteral Nutrition ,medicine.medical_specialty ,Hydrocortisone ,Globulin ,Nitrogen ,medicine.drug_class ,Protein metabolism ,Critical Care and Intensive Care Medicine ,chemistry.chemical_compound ,Enteral Nutrition ,Fish Oils ,Double-Blind Method ,Transcortin ,Internal medicine ,Intensive care ,medicine ,Humans ,Interleukin 6 ,Lymphotoxin-alpha ,Food, Formulated ,biology ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,business.industry ,Interleukin ,Methylhistidines ,Fish oil ,Dietary Fats ,Endocrinology ,chemistry ,biology.protein ,Corticosteroid ,Female ,Burns ,Energy Intake ,business - Abstract
To analyze the effect of low-fat nutritional solutions, with or without fish oil, on serum interleukin (IL)-6, and to explore the relationships between IL-6, corticosteroid-binding globulin (CBG; the main cortisol carrier in plasma), and protein metabolism in severely burned adult patients.Randomized, double-blind study with control and low fat-fed groups.Burn center of Hôtel-Dieu Hospital of Montréal.Thirty-seven men and women with thermal burn injury over20% of body surface area and no other known medical condition.Within 24 hrs after admission, nutritional support was started through a gastroenteral tube inserted under endoscopic guidance. The goal for energy intake was calculated using the Curreri formula, and was adjusted with biweekly measurements of resting energy expenditure. Patients were randomly assigned to one of the following groups: control (35% of energy as fat); low fat 1 (15% of energy as fat); and low fat 2 (50% of fat in the form of fish oil).Tumor necrosis factor (TNF)-alpha and TNF-beta, IL-6, CBG, and cortisol free fraction were measured every 3 days for 28 days. Nitrogen balance and urinary 3-methylhistidine excretion were measured daily. IL-6 concentrations were high in all patients, with the highest value (460 +/- 111 units/mL) observed on day 4. Concentrations of IL-6 were higher in control patients than in low fat-fed patients between days 13 and 28, but not between days 1 and 13. Multivariate analysis showed that IL-6, total body surface area burned, and sepsis scores were independent predictors of CBG between days 1 and 13 (n = 170; p.00001). High IL-6 concentrations were predictors of low CBG concentrations and high cortisol free fractions. There was no relationship between IL-6, nitrogen balance, and 3-methylhistidine excretion. TNF-alpha and TNF-beta activity measurements by biological assay showed no correlation with other factors measured.a) Low-fat feeding, with or without fish oil, does not change the early production of IL-6 after burn injury; b) serum IL-6 is negatively correlated with CBG, which supports the hypothesis that this cytokine inhibits hepatic CBG production; and c) IL-6 does not appear to directly influence protein metabolism in burn patients.
- Published
- 1998
- Full Text
- View/download PDF
32. Muscle strength in individuals with healed burns
- Author
-
Diane M. M. St-Pierre, Dominique R. Garrel, Robert Forget, and Manon Choinière
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Elbow ,Physical Therapy, Sports Therapy and Rehabilitation ,Physical exercise ,Severity of Illness Index ,Reference Values ,Surveys and Questionnaires ,Severity of illness ,medicine ,Humans ,Wound Healing ,Muscle Weakness ,Rehabilitation ,business.industry ,Burn center ,Middle Aged ,Surgery ,Cross-Sectional Studies ,medicine.anatomical_structure ,Physical Fitness ,Female ,medicine.symptom ,Burns ,business ,Total body surface area ,Body mass index ,Muscle contraction - Abstract
Objective: To quantify the long-term effects of burns on muscle strength and to investigate the impact of the initial severity of the trauma on muscle strength. Design: Cross-sectional study comparing individuals with healed burns to nonburned control individuals matched for age, gender, body mass index, and physical activity level. Setting: Subjects were selected from the data bank of a burn center of a large Montreal teaching hospital and tested in a university laboratory. Patients: Thirty subjects (mean age, 36.3 ± 11.5yrs) with second- and third-degree burns covering 15% to 75% of total body surface area (TBSA) (mean, 35.5% ± 15.9%) were evaluated more than 1 year after discharge (mean, 37.3 ± 20.4 months; range, 15 to 92 months). Thirty unburned subjects were recruited from the community at large Main Outcome Measure: Maximal torque, work, and power developed by the elbow and knee flexors and extensors. Results: Subjects with burns of >30% of TBSA produced significantly less torque, work, and power in the quadriceps than control subjects (15.2% to 20.5% depending on velocity [p < .05]). The ability to develop muscle power at the elbow was also compromised in the severely burned subjects (19.2% in extension and 18.7% in flexion [p = .07]) at the faster velocities. No differences were observed between controls and patients with small burn injuries (TBSA of 30%) had weaker muscles even years after the trauma, suggesting either an inability to fully recover or insufficient rehabilitation.
- Published
- 1998
- Full Text
- View/download PDF
33. Role of the autonomic nervous system in the thermogenic response to food in lean individuals
- Author
-
Dominique R. Garrel and L. De Jonge
- Subjects
Adult ,Atropine ,Male ,medicine.medical_specialty ,Adolescent ,Physiology ,Endocrinology, Diabetes and Metabolism ,Propranolol ,Autonomic Nervous System ,Eating ,Heart Rate ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,Ingestion ,Meal ,Gastric emptying ,business.industry ,Healthy subjects ,Parasympatholytics ,Autonomic nervous system ,Endocrinology ,Injections, Intravenous ,Body Composition ,Sympatholytics ,Female ,Energy Metabolism ,business ,Perfusion ,Body Temperature Regulation ,medicine.drug - Abstract
The aim of this study was to determine the role of the autonomic nervous system (ANS) in obligatory and facultative components of the thermogenic response to food (TRF). Nineteen lean, healthy subjects participated in this study, which comprised two protocols, each exploring one component of the ANS. In the first experimental group, propranolol (prime: 80 micrograms/kg; continuous: 1 microgram.kg-1.min-1) was infused intravenously to inhibit sympathetic nervous activity (SNA), whereas in the second group atropine (prime: 5 micrograms/kg; continuous: 5 micrograms.kg-1.min-1) was used to inhibit parasympathetic nervous activity (PNA). The TRF was measured on four occasions: 1) after oral ingestion of a breakfast, during 0.9% NaCl perfusion, 2) after oral ingestion of the same breakfast, during the perfusion of one of the drugs, 3) after intragastric injection of a pureed form of the same meal as in part 1, during 0.9% NaCl perfusion, and 4) after intragastric feeding, during the administration of one of the drugs. Energy expenditure was measured by indirect calorimetry for 30 min before and 6 h after ingestion of the meal. Facultative TRF was defined as the difference between oral and intragastric TRF. Intragastric feeding significantly reduced TRF in both studies: 6.6 +/- 1.0 vs. 8.7 +/- 0.8% of the ingested energy in the SNA study and 5.5 +/- 1.6 vs. 7.4 +/- 3.1% in the PNA study. During propranolol infusion, TRF was significantly lower than it was during saline infusion after oral feeding (6.9 +/- 1.0% vs. 8.7 +/- 0.8% of ingested energy) but not after intragastric feeding. During atropine administration, TRF was reduced after both oral and intragastric feeding, although statistical significance was not reached in the latter. Atropine administration decreased gastric emptying (measured with an isotopic method) 2 h postingestion by 50%. These results show that the SNA is necessary for the facultative component of TRF to occur in humans. The role of the PNA appears to be related to its action on gastric emptying.
- Published
- 1997
- Full Text
- View/download PDF
34. [Radioanatomy of rhinopharyngeal carcinoma]
- Author
-
A L, Braccini, S, Haberer-Guillerm, D, Azria, R, Garrel, G, Pierre, Y, Auge, and P, Boisselier
- Subjects
Diagnostic Imaging ,Nasopharyngeal Carcinoma ,Carcinoma ,Humans ,Nasopharyngeal Neoplasms ,Radiotherapy, Conformal - Abstract
Rhinopharyngeal cancer is one of the best indications for conformal radiotherapy with modulated intensity. Due to the high dose gradient, accurate delineation of target volumes and organs at risk is a critical success factor with this technology. This requires a good knowledge of rhinopharyngeal radioanatomy and optimal imaging techniques.
- Published
- 2013
35. Effects of RU 486 on energy expenditure and meal tolerance in normal men
- Author
-
Dominique R. Garrel, N Jobin, and L de Jonge
- Subjects
Adult ,Blood Glucose ,Male ,medicine.medical_specialty ,Time Factors ,Hydrocortisone ,Nitrogen ,Administration, Oral ,Medicine (miscellaneous) ,Biology ,Placebo ,Hormone Antagonists ,Double-Blind Method ,Internal medicine ,medicine ,Animals ,Humans ,Insulin ,Ingestion ,Resting energy expenditure ,Glucocorticoids ,Morning ,Meal ,Nutrition and Dietetics ,digestive, oral, and skin physiology ,Rats ,Mifepristone ,Postprandial ,Endocrinology ,Creatinine ,Basal metabolic rate ,Energy Metabolism ,Thermogenesis - Abstract
To evaluate the possible actions of glucocorticoids on resting energy expenditure and the thermogenic response to food in man.The morning after administration of RU 486 or placebo, resting metabolic rate (RMR) and the thermogenic response to food (TRF), were measured after the ingestion of a standardized meal in 12 healthy male volunteers. Plasma glucose (PG) and insulin (PI) concentrations were also measured at regular intervals.1) After RU 486 administration, plasma cortisol was elevated throughout the test comparatively to placebo. 2) Fraction and concentration of free cortisol were also higher after RU 486 than after placebo. 3) Corticosteroid-binding-globulin (CBG) was similar in both experimentations. 4) RMR was not different after RU 486 (1656 +/- 144 kcal/day) or after placebo (1632 +/- 120 kcal/day). 5) TRF was not different after RU 486 or placebo (54 +/- 12 kcal vs 59 +/- 13 kcal over a 6 hour period for RU 486 and placebo, respectively). 6) Baseline glucose concentrations were similar at baseline but PG was higher 90 minutes postprandial with RU 486: 5.3 +/- 1.7 mmol/L vs 3.7 +/- 0.8 mmol/L for placebo. 7) Plasma insulin was similar at baseline but it was significantly higher at 90 minutes postprandial after RU 486 (347 +/- 143 vs 241 +/- 73 pmol/L for RU 486 and placebo, respectively).This study shows that acute inhibition of glucocorticoid action does not alter RMR and TRF in healthy men and that a mild deterioration of glucose tolerance follows the ingestion of RU 486.
- Published
- 1996
- Full Text
- View/download PDF
36. Should We Still Use the Harris and Benedict Equations?
- Author
-
Lilian H.M. De Jonge, Dominique R. Garrel, and Nathalie Jobin
- Subjects
Adult ,Male ,Adolescent ,030309 nutrition & dietetics ,Medicine (miscellaneous) ,Measured RMR ,World health ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Bias ,Predictive Value of Tests ,Healthy volunteers ,Humans ,Medicine ,In patient ,Sex Characteristics ,0303 health sciences ,Nutrition and Dietetics ,business.industry ,Reproducibility of Results ,Calorimetry, Indirect ,Middle Aged ,Predictive value ,Nutrition Assessment ,Quartile ,Basal metabolic rate ,Lean body mass ,Female ,030211 gastroenterology & hepatology ,Basal Metabolism ,business ,Mathematics ,Demography - Abstract
Resting metabolic rate (RMR) is commonly predicted using the Harris-Benedict (HB) equations, but an overestimation of 10% to 15% is normally found. More recent studies have proposed equations with a better predictive value. In this study, we explore the relationship between measured RMR and HB in 67 healthy volunteers and in a data set from the literature and compared measured RMR with six more recent equations. Mean differences between RMR and HB were 21%, 12%, 10%, and 4% for the lowest to the highest RMR quartile, respectively, and 20%, 8%, 6%, and -4% for Owen's subjects. Among the six recent equations, only the World Health Organization (WHO) equations predicted RMR within 10% in 100% of the cases. Our results suggest that overestimation of RMR by HB is not a homogenous finding but is inversely related to RMR. This may have important implications for predicting RMR in women and in patients with diminished lean body mass. In addition, the WHO equations appear more precise than the HB equations.
- Published
- 1996
- Full Text
- View/download PDF
37. Corticosteroid-Binding Globulin during Inflammation and Burn Injury: Nutritional Modulation and Clinical Implications
- Author
-
Dominique R. Garrel
- Subjects
medicine.medical_specialty ,Burn injury ,Hydrocortisone ,Globulin ,Endocrinology, Diabetes and Metabolism ,Inflammation ,Nutritional modulation ,Endocrinology ,Transcortin ,Internal medicine ,medicine ,Animals ,Humans ,Nutritional Physiological Phenomena ,Diet, Fat-Restricted ,Pregnancy ,biology ,medicine.disease ,Fish oil ,Immunology ,biology.protein ,medicine.symptom ,Burns ,hormones, hormone substitutes, and hormone antagonists - Abstract
Corticosteroid-binding globulin (CBG) is the main carrier of glucocorticoids in mammals. Serum CBG shows little physiological variation with the exception of pregnancy. Experimental inflammation and burn injury decrease serum CBG in rats and while the mechanism of this effect is unknown, in vitro experiments suggest that interleukin-6 may be involved. In severely burned patients, we have found that CBG was markedly decreased within a few hours postinjury. This decrease lasted about 2 weeks and was accompanied by an increase in the free fraction of serum cortisol. In addition, serum CBG responded to dietary manipulation in these patients, with low fat feeding resulting in higher serum CBG concentrations and lower serum-free cortisol values. This feeding suggests that during severe stress, CBG may be important in regulating the amount of cortisol reaching target tissues such as the immune system and wounds.
- Published
- 1996
- Full Text
- View/download PDF
38. Improved Clinical Status and Length of Care With Low-Fat Nutrition Support in Burn Patients
- Author
-
François Larivière, Agnès Emptoz-Bonneton, Nazem Naman, Nathalte Jobin, Michel Pugeat, Mohammad Razi, and Dominique R. Garrel
- Subjects
Adult ,Male ,Parenteral Nutrition ,medicine.medical_specialty ,Nitrogen balance ,Calorie ,Adolescent ,Hydrocortisone ,030309 nutrition & dietetics ,Nutritional Status ,Medicine (miscellaneous) ,Enteral administration ,Gastroenterology ,law.invention ,Excretion ,03 medical and health sciences ,Enteral Nutrition ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,Fatty Acids, Omega-3 ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,0303 health sciences ,Nutrition and Dietetics ,business.industry ,Proteins ,Length of Stay ,Middle Aged ,Methylhistidines ,Fish oil ,Dietary Fats ,Surgery ,Parenteral nutrition ,Female ,030211 gastroenterology & hepatology ,Burns ,Energy Intake ,business - Abstract
The optimal amount and type of fat in the nutrition support of burned patients have not been determined. The aim of this study was to test low-fat nutritional solutions, with or without fish oil, on protein metabolism, morbidity, and length of care in severely burned adults.In a prospective randomized clinical trial, 43 patients were assigned to one of the following groups: control (35% fat), low-fat solution (ie, 15% of total calories as fat), low-fat with fish oil, given for 30 days. Nitrogen balance, urinary 3-methylhistidine excretion, urinary cortisol, and clinical status were measured daily. Corticosteroid-binding globulin and total and free serum cortisol were measured every 3 days.Compared with controls, patients on low-fat support had fewer cases of pneumonia: 3/24 vs 7/13 (p = .02), better respiratory and nutrition status, and shorter time to healing: 1.2 vs 1.8 days/% burned area (p = 0.01). There was no difference in nitrogen balance between groups, and 3-methylhistidine excretion was higher and serum free cortisol was lower in log-fat--fed patients than in controls. There was no difference between the two low-fat groups in any of the parameters measured.This study showed that low-fat nutrition support decreases infectious morbidity and shortens length of stay in burn patients. Fish oil does not seem to add clinical benefit to low-fat solutions. In addition, this study provides the first evidence that nutrition intervention modulates cortisol-binding globulin and the concentration of free circulating cortisol after a severe stress.
- Published
- 1995
- Full Text
- View/download PDF
39. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism
- Author
-
D. R. Garrel
- Subjects
Endocrinology ,Endocrinology, Diabetes and Metabolism ,Biochemistry (medical) ,Clinical Biochemistry ,Biochemistry - Published
- 1995
- Full Text
- View/download PDF
40. Thermogenic response to feeding in severely burned patients: relation to resting metabolic rate
- Author
-
L. de Jonge and Dominique R. Garrel
- Subjects
Adult ,Male ,Parenteral Nutrition ,medicine.medical_specialty ,Nitrogen ,Energetic cost ,Critical Care and Intensive Care Medicine ,Eating ,Enteral Nutrition ,Internal medicine ,medicine ,Humans ,Aged ,business.industry ,Calorimetry, Indirect ,General Medicine ,Middle Aged ,Endocrinology ,Energy expenditure ,Basal metabolic rate ,Emergency Medicine ,Hypermetabolism ,Female ,Surgery ,Basal Metabolism ,Burns ,Energy Metabolism ,business ,Thermogenesis ,Federal state - Abstract
Energy expenditure (EE) was measured one to five times by indirect calorimetry for 1 h after an overnight fast, and for 2 h after starting feeding in 19 severely burned patients (TBSA20 per cent) for a total of 36 tests. Twelve tube-fed volunteers served as controls. Thermogenic response to feeding (TRF) was calculated as the percentage of energy intake and hypermetabolism as the percentage of values obtained with the Harris-Benedict formula (%HB). Measured energy expenditure values were compared with values given by three predicting formulae. TRF was present in 10 out of the 33 measurements. Fasting EE was not different between the tests with and without TRF, but %HB was different between the two groups: 121.1 +/- 25.8 vs 157.8 +/- 32.0 per cent (tests with and without TRF, respectively (P0.01)). TRF was always absent when %HB was higher than 50. When TRF was present it was not statistically different from the control values. None of the three predicting formulae gave values within 10 per cent of the measured values in more than 25 per cent of the patients. We conclude that TRF is suppressed in burned patients with marked hypermetabolism, and that EE measured in the fed state reflects resting expenditure accurately in these patients. In addition, EE cannot be predicted from existing formulae.
- Published
- 1993
- Full Text
- View/download PDF
41. Insulin-like growth factor-l blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn
- Author
-
Dominique R. Garrel, Thierry Abribat, Paul Brazeau, and Isabelle Davignon
- Subjects
Adult ,Male ,medicine.medical_specialty ,Nitrogen balance ,Burn injury ,Time Factors ,Nitrogen ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Nutritional Status ,Normal values ,Post injury ,Insulin-like growth factor ,Injury Severity Score ,Endocrinology ,Internal medicine ,medicine ,Humans ,Insulin-Like Growth Factor I ,business.industry ,Age Factors ,Radioimmunoassay ,Middle Aged ,Pathophysiology ,Acute Disease ,Female ,Burns ,business ,Total body surface area ,Burns, Inhalation - Abstract
OBJECTIVES Insulin-like growth factor-I (IGF-I) is a polypeptide growth factor that stimulates protein synthesis. The aims of this study were to determine (1) the effect of a severe burn on blood IGF-I levels and (2) the variables controlling IGF-I level variations during recovery of these hypermetabolic patients. PATIENTS Eleven patients, nine men and two women (age range 22-55 years) were studied for 25 days following a severe burn (18-75% of total body surface area, mean 36%). Nitrogen balances were recorded daily and total IGF-I levels were measured every 3 days. MEASUREMENTS IGF-I was extracted from serum using a validated formic acid-acetone methodology, then measured by a double antibody radioimmunoassay. IGF-I levels were compared to those of a reference healthy population. RESULTS Within 24 hours following injury, IGF-I levels were low in all patients when compared to normal values for the same age range (mean +/- SEM of all patients, 131 +/- 26 micrograms/l). They remained low for the first week (days 4 and 7, 109 +/- 16 micrograms/l), then increased to reach normal values at the end of the study period (days 10-16, 144 +/- 19 micrograms/l, P = 0.005 when compared to days 4-7; days 19-25, 206 +/- 30 micrograms/l, P = 0.008 when compared to days 10-16). IGF-I levels were negatively correlated with age in the second phase of recovery only (days 10-16, r = -0.70, P < 0.05; days 19-25, r = -0.75, P < 0.01) and with severity of burn between days 19 and 25 (r = -0.62, P < 0.05). The presence of bronchial burn injury tended to lower IGF-I blood concentration (P = 0.08). Whereas IGF-I concentrations increased in the later phase of recovery, nitrogen balances did not. As a result, there was no significant correlation between these parameters. CONCLUSIONS IGF-I levels followed a biphasic pattern in severely burned patients. They dropped dramatically in response to the traumatic shock, then increased during recovery. The degree of increase was dependent on the age of the patient and on the severity of the burn, but was not associated with an improvement in the nitrogen balance.
- Published
- 1993
- Full Text
- View/download PDF
42. No change in glucose tolerance and substrate oxidation after a high-carbohydrate, low-fat diet
- Author
-
Isabelle Leclerc, Isabelle Davignon, Denise Lopez, and Dominique R. Garrel
- Subjects
Adult ,Blood Glucose ,Male ,medicine.medical_specialty ,Very low-density lipoprotein ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Radioimmunoassay ,Calorimetry ,Fatty Acids, Nonesterified ,Lipoproteins, VLDL ,chemistry.chemical_compound ,Endocrinology ,Internal medicine ,Blood plasma ,Dietary Carbohydrates ,medicine ,Humans ,Insulin ,Analysis of Variance ,Triglyceride ,Chemistry ,Substrate (chemistry) ,Metabolism ,Glucose Tolerance Test ,Carbohydrate ,Dietary Fats ,Lipoproteins, LDL ,Cholesterol ,Glucose ,Female ,Oxidation-Reduction ,Lipoprotein - Abstract
Possible changes in glucose tolerance and substrate oxidation after a high-carbohydrate, low-fat diet were studied in seven healthy volunteers. Each subject consumed two experimental diets for 1 week after 1 week on a stabilization diet; diet no. 1 11% fat and 64% carbohydrates, and diet no. 230% fat and 45% carbohydrates. At the end of each experimental week, plasma levels of glucose, insulin, and free fatty acids were measured before and every 30 minutes for 6 hours after a 75-g oral glucose challenge. At the same time, energy expenditure and substrate oxidation were measured by indirect calorimetry. Plasma lipid and lipoprotein levels were measured at the end of one stabilization period and at the end of each diet. Plasma glucose concentrations and areas under the curve of glucose concentrations were identical after the two experimental periods; the means ± standard deviation for the values at 120 minutes were 6.4 ± 0.3 and 6.4 ± 0.6 mmol/L after diets no. 1 and 2, respectively, and areas under the curve were 1,853 ± 115 and 1,862 ± 211 mmol · min/L after diets no. 1 and 2, respectively. Similarly, plasma concentrations of insulin and free fatty acids after glucose ingestion were unaffected by the dietary changes. Energy expenditure increased after glucose administration, and this thermic effect of glucose was identical after the two experimental diets at 4.2% ± 1.4%, and 3.9% ± 1.4% of ingested energy for diets no. 1 and 2, respectively. Substrate oxidation rates were also identical for both the fasted and post-glucose periods after the two diets. Total cholesterol, very-low-density lipoprotein (VLDL), and low-density lipoprotein (LDL) levels showed no significant change between the two diets, but plasma high-density lipoprotein (HDL) concentrations were lower after the high-carbohydrate diet at 1.02 ± 0.10 and 1.15 ± 0.10 mmol/L for diets no. 1 and 2, respectively (P < .05), and triglyceride concentrations were higher after each experimental diet than after the stabilization diet at 1.11 ± 0.04, 1.29 ± 17, and 0.87 ± 0.12 for diets no. 1 and 2 and the stabilization diet, respectively (P < .01). These data do not support the hypothesis of a metabolic adaptation toward increased glucose tolerance and glucose utilization induced by a high-carbohydrate, low-lipid diet in healthy subjects. Furthermore, changes observed in plasma lipoprotein concentrations favor the concept that such a diet may increase the risk for cardiovascular disease.
- Published
- 1993
- Full Text
- View/download PDF
43. Effect of burn injury on corticosteroid-binding globulin levels in plasma and wound fluid
- Author
-
Limin Zhang, Geoffrey L. Hammond, Dominique R. Garrel, and Xian‐F. Zhao
- Subjects
medicine.medical_specialty ,Burn injury ,Globulin ,biology ,medicine.diagnostic_test ,business.industry ,Decreased Concentration ,Dermatology ,medicine.disease ,Bioavailability ,Endocrinology ,Western blot ,Transcortin ,Internal medicine ,biology.protein ,Scalding ,Medicine ,Surgery ,business ,Wound healing - Abstract
Corticosteroids exert inhibitory effects on wound healing. They circulate, largely bound to corticosteroid-binding globulin, and the plasma concentrations of this protein determine their bioavailability. The amount of corticosteroid-binding globulin in wounds and the related effects of burn injury are not known. We have therefore measured corticosteroid-binding globulin in serum and wound fluid obtained from subcutaneously implanted sponges, retrieved 1, 3, and 10 days after insertion in rats. The effect of burning was studied by comparing rats that had a small scald burn with sham-burned control rats. In serum, corticosteroid-binding globulin levels were lower in burned rats than in control animals: the difference was 22%, 28%, and 37% for days 1, 3, and 10, respectively (p < 0.05 for each comparison), and values at day 1 were lower than at days 3 and 10 in control rats (p < 0.05) but not in burned rats. In wound fluid, corticosteroid-binding globulin levels were lower in burned rats than in control animals: the difference was 23%, 24%, and 34% for days 1, 3, and 10, respectively (p < 0.01 for all comparisons), and the values were significantly higher (p < 0.05) at day 1 when compared with values at day 10 in both groups. We therefore conclude that a small burn injury has significant effects on levels of corticosteroid-binding globulin on serum and wound fluid corticosteroid-binding globulin. The decreased concentration of wound fluid corticosteroid-binding globulin at day 10 versus day 1, with a concomitant increase in serum corticosteroid-binding globulin, suggests an accelerated degradation of the protein within the wound; this phenomenon is exaggerated by the burn injury. This is supported by Western blot analysis, which revealed the appearance of a small polypeptide that reacts with an antiserum against rat corticosteroid-binding globulin in wound fluid at day 10.
- Published
- 1993
- Full Text
- View/download PDF
44. Decreased hypoglycemic effect of insulin at night in insulin-dependent diabetes mellitus and healthy subjects
- Author
-
D. R. Garrel
- Subjects
Endocrinology ,Endocrinology, Diabetes and Metabolism ,Biochemistry (medical) ,Clinical Biochemistry ,Biochemistry - Published
- 1992
- Full Text
- View/download PDF
45. [Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification]
- Author
-
A, El Ayoubi, F, Poizat, R, Garrel, V, Costes, B, Guerrier, L, Essakalli, M, Kzadri, and L, Crampette
- Subjects
Adult ,Homeodomain Proteins ,Male ,Keratin-7 ,Microfilament Proteins ,Nose Neoplasms ,Kaplan-Meier Estimate ,Keratin-20 ,Adenocarcinoma ,Middle Aged ,Prognosis ,World Health Organization ,Immunohistochemistry ,ErbB Receptors ,Ethmoid Sinus ,Biomarkers, Tumor ,Disease Progression ,Trans-Activators ,Humans ,CDX2 Transcription Factor ,Female ,Paranasal Sinus Neoplasms ,Aged ,Retrospective Studies - Abstract
The WHO 2005 histological classification separates sinonasal adenocarcinoma (ADC) into three classes: intestinal-type adenocarcinoma (ITAC), low-grade sinonasal ADC and high-grade sinonasal ADC. The goal of this study was to check the relevance of this classification on the prognosis of patients treated for ADC.All the files of patients treated consecutively in the ENT department of the Montpellier University Hospital for ADC between 1980 and 2003 were retrospectively re-examined. Each case was reviewed for anatomical and pathological data based on the immunohistochemistry results according to the WHO 2005 classification, with a study of a panel of markers: cytokeratin 7 (CK7), cytokeratin 20 (CK20), Villin, CDX2 and EGFR. The epidemiologic data, the methods of treatment and the follow-up were studied. The survival probabilities were calculated using the Kaplan-Meier method and the survival graphs were compared using a log-rank test.Sixty-two files were reviewed. Twelve patients were reclassified into the adenoid cystic carcinoma category and excluded from the study. In the 50 remaining cases, there were 36 ITAC cases, four low-grade ADC cases and 10 high-grade dedifferentiated carcinomas. For all of the ADC cases, the total survival at 5 years and without recurrence was 64 and 52%, respectively. The analysis of the three subgroups showed a total survival of 72.2% for ITAC, 100% for low-grade and 20% for high-grade ADC with a significant difference (p=0.044). This immunohistochemical distinction was mainly based on the expression of CK20 found in 98% of the ITAC cases and absent in low- and high-grade ADC patients.The WHO 2005 classification for sinonasal ADC provides a valuable prognosis by showing a difference in the progression profile between ITAC, low-grade ADC and high-grade ADC. Moreover, broader studies should be conducted to investigate the different subtypes of ITAC.
- Published
- 2009
46. Chronic administration of growth hormone-releasing factor increases wound strength and collagen maturation in granulation tissue
- Author
-
Isabelle Reeves, Paul Brazeau, Limin Zhang, Pierrette Gaudreau, and Dominique R. Garrel
- Subjects
Male ,medicine.medical_specialty ,Proline ,Glycine ,Growth Hormone-Releasing Hormone ,Hydroxyproline ,chemistry.chemical_compound ,Tensile Strength ,Internal medicine ,medicine ,Animals ,chemistry.chemical_classification ,Wound Healing ,Chemistry ,Granulation tissue ,Fatty acid ,Rats, Inbred Strains ,Growth hormone–releasing hormone ,Rats ,Amino acid ,Microscopy, Electron ,medicine.anatomical_structure ,Endocrinology ,Growth Hormone ,Granulation Tissue ,Surgery ,Collagen ,Wound healing - Abstract
The effects of chronic administration of growth hormone-releasing factor (GRF) on wound healing were studied in rats. Cutaneous wound strength was measured by tensometry at 5, 10, and 14 days postwounding in rats implanted with a slow-release pellet which contained a compressed mixture of a fatty acid and [desamino Tyr1, D-Ala2, Ala15]hGRF(1-29)NH2 or the fatty acid alone. There was a significant increase in wound tensile strength in GRF-treated rats compared to controls at each measurement: Day 5, 130 +/- 12 vs 97 +/- 14 g; Day 10, 402 +/- 18 vs 280 +/- 11 g; Day 14, 830 +/- 17 vs 614 +/- 14 g (P less than 0.01 for each value). Granulation tissue obtained from subcutaneously implanted polyvinyl alcohol sponges encased in silicone tubing was also studied. The amount of collagen deposited in the granulation tissue was estimated by measuring the hydroxyproline (Hyp) content of sponges retrieved 5, 10, and 14 days postinsertion from GRF-treated and control rats. Hyp content (nmole/mg sponge) was similar in both treated and control animals at each measurement: Day 5, 1.7 +/- 0.2 vs 2.2 +/- 0.2; Day 10, 31.9 +/- 4.1 vs 26.7 + 0.4; and Day 14, 41.6 +/- 7.3 vs 38.5 +/- 4.4. Hyp/proline, Hyp/glycine, and glycine/total amino acid ratios, evaluated after 10 days, were also similar in both groups. Collagen from the granulation tissue of sponges retrieved after 14 days from treated and control rats was studied by electron microscopy (magnifications, 7,100 and 22,720).(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1991
- Full Text
- View/download PDF
47. Milk- and soy-protein ingestion: acute effect on serum uric acid concentration
- Author
-
D Brulé, M Verdy, D R Garrel, C Martin, P Hamet, and C PetitClerc
- Subjects
Adult ,Male ,medicine.medical_specialty ,animal structures ,Uricosuric ,Medicine (miscellaneous) ,Plant Proteins, Dietary ,chemistry.chemical_compound ,Internal medicine ,Casein ,medicine ,Humans ,Ingestion ,Amino Acids ,Soy protein ,Lactalbumin ,Analysis of Variance ,Nutrition and Dietetics ,Caseins ,Metabolism ,Uric Acid ,Endocrinology ,chemistry ,Creatinine ,Soybean Proteins ,Urea ,Uric acid ,Female ,Dietary Proteins - Abstract
Acute effect of the ingestion of 80 g each of casein, lactalbumin, and soybean isolate on serum and urinary uric acid concentrations was investigated in 10 healthy subjects. Serum and urinary uric acid concentrations were measured before and after the ingestion of proteins. Serum uric acid decreased significantly 3 h after ingestion of lactalbumin and casein but increased after soybean consumption. Urate clearance was significantly increased after ingestion of each of the three proteins. Multivariate analysis of urate clearance during lactalbumin and casein loads showed that independent correlation was obtained for serum alanine and urea concentration. These results demonstrate that, in addition to their known uricosuric effect, milk proteins acutely decrease serum uric acid concentration. Analysis of the effects of lactalbumin and casein on urinary uric acid elimination suggests that the uricosuric effect of proteins is a multifactorial phenomenon.
- Published
- 1991
- Full Text
- View/download PDF
48. Length of Care in Patients with Severe Burns with or without Early Enteral Nutritional Support
- Author
-
Carol S. Ireton-Jones, Dominique R. Garrel, Isabelle Davignon, and Denise Lopez
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Adolescent ,Body Surface Area ,Enteral administration ,Enteral Nutrition ,Lag time ,medicine ,Humans ,In patient ,Severe burn ,General Nursing ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Body Weight ,Rehabilitation ,Retrospective cohort study ,Length of Stay ,Middle Aged ,Surgery ,Respiratory injury ,Anesthesia ,General Health Professions ,Hospital admission ,Emergency Medicine ,Regression Analysis ,Female ,Burns ,Energy Intake ,business ,Total body surface area - Abstract
The possible influence of early enteral nutritional support on the length of care was explored retrospectively in 25 patients with burns greater than 20% total body surface area (TBSA). Patients were divided into two groups according to the time of their admission: group 1, from July 1986 to February 1987 (n = 12) and group 2, from July 1987 to January 1988 (n = 13). The only difference in treatment between the two groups was the start of early enteral nutritional support in group 2. Age, percent TBSA burned, surfaces of skin grafts, associated respiratory injury, and medical condition were identical in both groups. The following parameters were compared: lag time between hospital admission and the beginning of nutritional support, energy intake, nitrogen intake during the 4-week postadmission period, and length of care. A regression analysis including all patients was also performed to identify the factors associated with length of care. Lag time was shorter in group 2 than in group 1: 3 +/- 2 days versus 7 +/- 2 days (p less than 0.01). Group 2 received more energy than group 1 during the first 2 weeks after admission: 120 +/- 54 kj/kg/day versus 73 +/- 34 kj/kg/day (p less than 0.05) and 175 +/- 36 kj/kg/day versus 137 +/- 41 kj/kg/day (p less than 0.05) for the first and the second week, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1991
- Full Text
- View/download PDF
49. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study
- Author
-
Marie-Eve Lavoie, Marie-Eve Mathieu, Éric Doucet, Antony D. Karelis, Rémi Rabasa-Lhoret, Dominique R. Garrel, and Martin Brochu
- Subjects
Blood Glucose ,medicine.medical_specialty ,Canada ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Medicine (miscellaneous) ,Intra-Abdominal Fat ,Body Mass Index ,Cohort Studies ,Endocrinology ,Insulin resistance ,Thinness ,Internal medicine ,medicine ,Glucose homeostasis ,Homeostasis ,Humans ,Insulin ,Obesity ,Aged ,Metabolic Syndrome ,Nutrition and Dietetics ,Postmenopausal women ,business.industry ,Middle Aged ,medicine.disease ,Postmenopause ,C-Reactive Protein ,Lean body mass ,Body Composition ,Female ,Insulin Resistance ,business ,Body mass index ,Visceral Obesity ,Metabolic profile - Abstract
Some insulin-resistant obese postmenopausal (PM) women are characterized by an android body fat distribution type and higher levels of lean body mass (LBM) compared to insulin-sensitive obese PM women. This study investigates the independent contribution of LBM to the detrimental effect of visceral fat (VF) levels on the metabolic profile. One hundred and three PM women (age: 58.0+/-4.9 years) were studied and categorized in four groups on the basis of their VF (higher vs. lower) and lean BMI (LBMI=LBM (kg)/height (m2); higher vs. lower). Measures included: fasting lipids, glucose homeostasis (by euglycemic/hyperinsulinemic clamp technique and 2-h oral glucose tolerance test (OGTT)), C-reactive protein (CRP) levels, fat distribution (by computed tomography (CT) scan), and body composition (by dual-energy X-ray absorptiometry). Women in the higher VF/higher LBMI group had lower glucose disposal and higher plasma insulin levels compared to the other groups. They also had higher plasma CRP levels than the women in the lower VF/lower LBMI group. VF was independently associated with insulin levels, measures of glucose disposal, and CRP levels (P
- Published
- 2008
50. [Untitled]
- Author
-
Marc G. Jeschke, Daren K. Heyland, Jonathan Pollack, Lucy Wibbenmeyer, Paul E. Wischmeyer, Nathan Kemalyan, Dominique R. Garrel, and Bruce Friedman
- Subjects
Glutamine ,Randomized controlled trial ,business.industry ,law ,Anesthesia ,Medicine ,Critical Care and Intensive Care Medicine ,business ,Enteral administration ,law.invention - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.